# Ir I (η 4 -diene) precatalyst activation by strong bases: formation of an anionic Ir III tetrahydride

Paven Kisten, Eric Manoury, Agustí Lledós, Adrian C Whitwood, Jason

Lynam, John Slattery, Simon B Duckett, Rinaldo Poli

► To cite this version:

Paven Kisten, Eric Manoury, Agustí Lledós, Adrian C Whitwood, Jason Lynam, et al., Ir I (η 4 -diene) precatalyst activation by strong bases: formation of an anionic Ir III tetrahydride. Dalton Transactions, 2023, 52 (8), pp.2495-2505. 10.1039/D2DT04036K. hal-03960179

HAL Id: hal-03960179

https://hal.science/hal-03960179

Submitted on 27 Jan 2023

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
ARTICLE

Ir'(η⁴-diene) precatalyst activation by strong bases: formation of an anionic Ir''' tetrahydride

Paven Kisten,a,b Eric Manoury,b Agustí Lledós,c Adrian C. Whitwood,a Jason Lynam,a John Slattery,a Simon B. Duckett*a and Rinaldo Poli*b,d

The reaction between [IrCl(COD)]₂ and dppe in a 1:2 ratio was investigated in detail under three different conditions. [IrCl(COD)(dppe)], **1**, is formed at room temperature in the absence of base. In the presence of a strong base at room temperarture, hydride complexes that retain the carbocyclic ligand in the coordination sphere are generated. In isopropanol, **1** is converted into [IrH(1,2,5,6-η²:η²-COD)(dppe)] (2) on addition of KO'Bu, with k₁₂ = (1.11±0.02)·10⁻⁴ s⁻¹, followed by reversible isomerisation to [IrH(1-κ-4,5,6-η³-C₈H₁₂)(dppe)] (3) with k₂₃ = (3.4±0.2)·10⁻⁴ s⁻¹ and k₃₂ = (1.1±0.3)·10⁻⁵ s⁻¹ to yield an equilibrium 5:95 mixture of **2** and **3**. However, when no hydride source is present in the strong base (KO'Bu in benzene or toluene), the COD ligand in **1** is deprotonated, followed by β-H elimination of an Ir¹-C₈H₁₁ intermediate, which leads to complex [IrH(1-κ-4,5,6-η³-C₈H₁₀)(dppe)] (4) selectively. This is followed by its reversible isomerisation to **5**, which features a different relative orientation of the same ligands (k₄₅ = (3.92±0.11)·10⁻⁴ s⁻¹; k₅-₄ = (1.39±0.12)·10⁻⁴ s⁻¹ in C₆D₆), to yield an equilibrated 32:68 mixture of **4** and **5**. DFT calculations assisted in the full rationalization of the selectivity and mechanism of the reactions, yielding thermodynamic (equilibrium) and kinetic (isomerization barriers) parameters in excellent agreement with the experimental values. Finally, in the presence of KO'Bu and isopropanol at 80 °C, **1** is tranformed selectively to K[IrH₄(dppe)] (6), a salt of an anionic tetrahydride complex of Ir''''. This product is also selectively generated from **2**, **3**, **4** and **5** and H₂ at room temperature, but only when a strong base is present. These results provide an insight into the catalytic action of [IrCl(LL)(COD)] complexes in the hydrogenation of polar substrates in the presence of a base.

Received 00th January 20xx,
Accepted 00th January 20xx

DOI: 10.1039/x0xx00000x

Introduction

Catalytic hydrogenation¹⁻⁶ and transfer hydrogenation⁷⁻¹⁴ are powerful tools for the reduction of a variety of polar unsaturated compounds, especially when using enantiopure chiral catalysts to convert prochiral substrates enantioselectively. Hydrogenation is of particular interest because of atom economy, especially if combined with H₂ production from renewable resources, whereas transfer hydrogenation makes use of safer reagents such as isopropanol or formate as hydrogen sources. Among the many catalysts used to carry out this transformation, those based on iridium have received considerable attention.¹⁵⁻²³ One of the most common ways to generate an active catalyst is ligand addition to commercially available [IrCl(COD)]₂ (COD = 1,5-cyclooctadiene) in the presence of a strong base. The transformations are commonly carried out in isopropanol, whether just as a solvent in hydrogenation or as a solvent and reagent in transfer hydrogenation. The role of the base has generally been ascribed

to the generation of the active hydride species via
chloride/isopropoxide exchange, followed by β-H elimination
with expulsion of acetone.

The precise nature of the active catalyst and the mechanism of
the catalytic cycle have remained relatively obscure in these
systems, with several possible pathways being viable in
principle.²⁴⁻²⁶ These include inner-sphere coordination/in-
sertion monohydride or dihydride pathways, as well as outer-
sphere pathways. A direct transfer of the isopropoxide C-
bonded H atom to the ketone substrate (Meerwein-Ponndorf-
Verley mechanism) is also possible in principle for transfer
hydrogenations. Several experimental and computational
contributions have addressed the mechanism of this process.²⁷-
⁴⁰ One crucial question that remains is whether the diene ligand
in the precatalyst remains coordinated to the metal in the
catalytically active species. Although it seems logical to presume
that COD is removed under hydrogenation conditions (i.e.
under H₂), whether this also occurs under transfer
hydrogenation conditions (particularly in warm isopropanol)
has been controversial. For instance, the [IrCl(diene)]₂/amino-
sulfide/HCOOH/NEt₃ system was reported to show diene-
dependent activity in the order COD > 1,5-Me₂COD > (COE)₂
(COE = cyclooctene) at 60°C.³¹ These observations led the
authors to propose that the diene or alkene remains metal
bound in the active species, but the intimate nature of the
active species remained obscure. In a combined experimental
and computational investigation of the acetophenone transfer

<footnote>a Department of Chemistry, University of York, Heslington, York, YO10 5DD U.K.,</footnote>

<footnote>b CNRS, LCC (Laboratoire de Chimie de Coordination), Université de Toulouse, UPS, INPT, 205 route de Narbonne, BP 44099, F-31077 Toulouse Cedex 4, France CNRS.</footnote>

<footnote>c Departament de Química, Universitat Autònoma de Barcelona, 08193 Barcelona, Catalonia, Spain.</footnote>

<footnote>d Institut Universitaire de France, 1, rue Descartes, 75231 Paris Cedex 05, France
Electronic Supplementary Information (ESI) available: [details of any supplementary
information available should be included here]. See DOI: 10.1039/x0xx00000x</footnote>
hydrogenation catalysed by [Ir(OMe)(COD)]$_2$/L at 60°C in isopropanol, where L is a P- or N-donor ligands, the active species was also considered to have the diene in the metal coordination sphere.³⁷ On the other hand, several other studies on similar systems, conducted under similar conditions, have shown evidence for the release of COD (either in a hydrogenated form or not).²⁷, ²⁸, ³⁸, ⁴⁰ In this contribution, we shall address two issues: i) the role of the base in Ir complex speciation; ii) the fate of the COD ligand under transfer hydrogenation conditions.

We have previously used complexes [IrCl(COD)(PSR$^a$)], (P,S$^R$ = chiral ferrocenyl phosphine thioethers, CpFe[1,2-C$_5$H$_3$(PPh$_2$)(CH$_2$SR)], R = Et, Bz, Ph, tBu), obtained by addition of P,S$^R$ to [IrCl(COD)]$_2$,⁴¹, ⁴² as precatalysts for ketone hydrogenation in isopropanol in the presence of NaOMe, resulting in excellent activities and enantioselectivities.⁴³ An experimental investigation revealed that COD is quantitatively removed from the catalytic system as a mixture of cyclooctene and cyclooctane,⁴⁴ which is not surprising under hydrogenation conditions (H$_2$). Thus, [IrH(P,S$^R$)(PrOH)] is presumably formed, at least initially. In addition, using the alternative [Ir(OMe)(COD)]$_2$ precatalyst still required the addition of a strong base to achieve the same high activities as the [IrCl(COD)]$_2$/(P,S$^R$)/NaOMe system. Thus, the role of the strong base cannot be limited to the generation of an active neutral hydride complex. A parallel DFT study, carried out with inclusion of [MeO(MeOH)$_5$] as a model of the strong base, revealed that the most stable species, i.e. likely to be the catalyst resting state, is not a neutral complex, but rather the [IrH$_4$(P,S$^R$)] ion.⁴⁴ This complex does not contain the mobile proton needed for a classical outer-sphere (Noyori-type)⁴⁵ mechanism, nor a vacant coordination site for ketone coordination/insertion. Instead, the catalytic action of this complex was rationalized via a new type of ionic mechanism, involving hydride transfer to the counterion-activated ketone to generate alkoxide, followed by ionic H$_2$ activation and alkoxide protonation. The calculated Gibbs energy span of 18.2 kcal mol$^{-1}$ is in good agreement with the experimental activity.⁴⁴

Anionic tetrahydride Ir$^{III}$ derivatives have previously been obtained by Morris *et al.* from the reaction of KH with [IrH$_5$L$_2$] (L = PPh$_3$, P$^t$Pr$_3$) in THF (equation 1).⁴⁶, ⁴⁷ However, the above-mentioned DFT study suggested that the [IrH$_4$(P,S$^R$)] complexes should be quantitatively generated by H$_2$ addition to [IrHL$_2$(PrOH)] through a sequence of deprotonation, H$_2$ oxidative addition and tPrOH reductive elimination steps (equation 2). Less intuitively, the same complexes were suggested by the DFT study to form favourably in the absence of free H$_2$, with the H equivalents needed being provided by isopropanol under transfer hydrogenation conditions (equation 3). Open questions, to be addressed in this contribution, are whether COD is removed by transfer hydrogenation and whether an anionic tetrahydridoiridium(III) complex is formed under catalytically relevant conditions, as predicted.

$$[\text{IrH}_5\text{L}_2] + \text{KH} \rightarrow \text{K}^+[\text{IrH}_4\text{L}_2]^+ + \text{H}_2 \quad (1)$$

$$[\text{IrHL}_2(\text{PrOH})] + \text{tPrO}^- + 2\text{H}_2 \rightarrow [\text{IrH}_4\text{L}_2]^+ + 2\text{tPrOH} \quad (2)$$

$$[\text{IrHL}_2(\text{PrOH})] + \text{tPrO}^- + 2\text{tPrOH} \rightarrow [\text{IrH}_4\text{L}_2]^+ + 4 \text{MeCOMe} \quad (3)$$

The extreme sensitivity of the [IrH$_4$L$_2$]$^-$ complex with L$_2$ = P,S$^R$ has not allowed us to generate and isolate, or spectroscopically detect, this putative anionic tetrahydride complex from [IrCl(COD)]$_2$/(P,S$^R$)/NaOMe via the processes shown in equations 2 or 3. We could demonstrate that the COD ligand in [IrCl(COD)]$_2$ is indeed hydrogenated to cyclooctene and cyclooctane by isopropanol under transfer hydrogenation conditions (reflux in isopropanol) in the presence of KO$^t$Bu and PPh$_3$.⁴⁸ However, the metallic complex in the final solution was not Morris' [IrH$_4$(PPh$_3$)$_2$]$^-$ but rather a mixture of isomeric fac- and mer-[IrH$_3$(PPh$_3$)$_3$].

In the present contribution, we present a detailed study of metal-complex activation and speciation using the strongly chelating ligand dppe as L$_2$, in order to probe species that would otherwise be too reactive when L$_2$ = P,S$^R$. Successful generation of a tetrahydride Ir$^{III}$ species, according to the strategy of equation 3, was indeed observed. We also present a new and thorough NMR investigation of the previously reported [IrH(COD)(dppe)] (two isomers, 2 and 3) which forms by the low-temperature action of the strong base on [IrCl(COD)(dppe)] (1), as well as the generation and characterization of two new hydride compounds (two isomers of [IrH(C$_8$H$_{10}$)(dppe)], 4 and 5), which result from the deprotonation of COD by the strong base in a non-protic solvent.

## Experimental

**General.** All reactions and purifications were carried out under nitrogen using high-vacuum or Schlenk-line techniques. The [Ir(COD)Cl]$_2$ and [Ir(COD)(dppe)Cl] precursors used in the experiments were synthesised according to published procedures.⁴⁹

**NMR instrumentation.** NMR spectra were recorded using the Bruker Ascend 500 MHz instrument available in the Centre for Hyperpolarization in Magnetic Resonance at York. NMR measurements were carried out using NMR tubes fitted with J. Young's valves. Deuterated solvents were dried using sodium metal. All samples were degassed on a high-vacuum line and the solutions were prepared in a glovebox by the addition of deuterated solvent (0.6 mL) to the solid complexes (~10 mg). Quantitative data for kinetic plots were obtained from the NMR spectra using inverse gated decoupling methods.

**Synthesis of [IrH(1,2,5,6-$\eta^2$:$\eta^2$-COD)(dppe)] (2) and [IrH(1-$\kappa$-4,5,6-$\eta^3$-C$_8$H$_{12}$)(dppe)] (3).** KO$^t$Bu (77 mg, 0.69 mmol) was added to an isopropanol (10 mL) solution of 1 (100 mg, 0.14 mmol) and stirred at room temperature for 1 hr, generating a cream-coloured solution. The solution was concentrated to dryness, the solid residue was dissolved in toluene (8 mL), and the resulting mixture was passed through an alumina lined pipette. The resulting solution was then concentrated *in vacuo*. Yield = 98 mg (0.14 mmol, 99 %). This reaction can also be performed using an equivalent amount of NaOMe. ESI-HRMS (m/z relative intensity %): [M-H]$^+$ Calcd: 699.1930; Found: 699.1933 (Figure S1). The $^1$H NMR analysis of the product
hydrogenation catalysed by [Ir(OMe)(COD)]₂/L at 60°C in isopropanol, where L is a P- or N-donor ligands, the active species was also considered to have the diene in the metal coordination sphere.³⁷ On the other hand, several other studies on similar systems, conducted under similar conditions, have shown evidence for the release of COD (either in a hydrogenated form or not).²⁷, ²⁸, ³⁸, ⁴⁰ In this contribution, we shall address two issues: i) the role of the base in Ir complex speciation; ii) the fate of the COD ligand under transfer hydrogenation conditions.

We have previously used complexes [IrCl(COD)(PSR)], (P,SR = chiral ferrocenyl phosphine thioethers, CpFe[1,2-C₅H₃(PPh₂)(CH₂SR)], R = Et, Bz, Ph, tBu), obtained by addition of P,SR to [IrCl(COD)]₂,⁴¹, ⁴² as precatalysts for ketone hydrogenation in isopropanol in the presence of NaOMe, resulting in excellent activities and enantioselectivities.⁴³ An experimental investigation revealed that COD is quantitatively removed from the catalytic system as a mixture of cyclooctene and cyclooctane,⁴⁴ which is not surprising under hydrogenation conditions (H₂). Thus, [IrH(P,SR)(PrOH)] is presumably formed, at least initially. In addition, using the alternative [Ir(OMe)(COD)]₂ precatalyst still required the addition of a strong base to achieve the same high activities as the [IrCl(COD)]₂/(P,SR)/NaOMe system. Thus, the role of the strong base cannot be limited to the generation of an active neutral hydride complex. A parallel DFT study, carried out with inclusion of [MeO(MeOH)₅]⁻ as a model of the strong base, revealed that the most stable species, i.e. likely to be the catalyst resting state, is not a neutral complex, but rather the [IrH₄(P,SR)]⁻ ion.⁴⁴ This complex does not contain the mobile proton needed for a classical outer-sphere (Noyori-type)⁴⁵ mechanism, nor a vacant coordination site for ketone coordination/insertion. Instead, the catalytic action of this complex was rationalized via a new type of ionic mechanism, involving hydride transfer to the counterion-activated ketone to generate alkoxide, followed by ionic H₂ activation and alkoxide protonation. The calculated Gibbs energy span of 18.2 kcal mol⁻¹ is in good agreement with the experimental activity.⁴⁴

Anionic tetrahydride Irill derivatives have previously been obtained by Morris et al. from the reaction of KH with [IrH₅L₂] (L = PPh₃, P'Pr₃) in THF (equation 1).⁴⁶, ⁴⁷ However, the above-mentioned DFT study suggested that the [IrH₄(P,SR)]⁻ complexes should be quantitatively generated by H₂ addition to [IrHL₂(PrOH)] through a sequence of deprotonation, H₂ oxidative addition and PrOH reductive elimination steps (equation 2). Less intuitively, the same complexes were suggested by the DFT study to form favourably in the absence of free H₂, with the H equivalents needed being provided by isopropanol under transfer hydrogenation conditions (equation 3). Open questions, to be addressed in this contribution, are whether COD is removed by transfer hydrogenation and whether an anionic tetrahydridoiridium(III) complex is formed under catalytically relevant conditions, as predicted.

$$[IrH_5L_2] + KH \rightarrow K^+[IrH_4L_2]^- + H_2 \quad (1)$$

$$[IrHL_2(PrOH)] + PrO^- + 2H_2 \rightarrow [IrH_4L_2]^- + 2 PrOH \quad (2)$$

$$[IrHL_2(PrOH)] + PrO^- + 2 PrOH \rightarrow [IrH_4L_2]^- + 4 MeCOMe \quad (3)$$

The extreme sensitivity of the [IrH₄L₂]⁻ complex with L₂ = P,SR has not allowed us to generate and isolate, or spectroscopically detect, this putative anionic tetrahydride complex from [IrCl(COD)]₂/(P,SR)/NaOMe via the processes shown in equations 2 or 3. We could demonstrate that the COD ligand in [IrCl(COD)]₂ is indeed hydrogenated to cyclooctene and cyclooctane by isopropanol under transfer hydrogenation conditions (reflux in isopropanol) in the presence of KO'Bu and PPh₃.⁴⁸ However, the metallic complex in the final solution was not Morris' [IrH₄(PPh₃)₂]⁻ but rather a mixture of isomeric fac- and mer-[IrH₃(PPh₃)₃].

In the present contribution, we present a detailed study of metal-complex activation and speciation using the strongly chelating ligand dppe as L₂, in order to probe species that would otherwise be too reactive when L₂ = P,SR. Successful generation of a tetrahydride Irill species, according to the strategy of equation 3, was indeed observed. We also present a new and thorough NMR investigation of the previously reported [IrH(COD)(dppe)] (two isomers, 2 and 3) which forms by the low-temperature action of the strong base on [IrCl(COD)(dppe)] (1), as well as the generation and characterization of two new hydride compounds (two isomers of [IrH(C₈H₁₀)(dppe)], 4 and 5), which result from the deprotonation of COD by the strong base in a non-protic solvent.

## Experimental

**General.** All reactions and purifications were carried out under nitrogen using high-vacuum or Schlenk-line techniques. The [Ir(COD)Cl]₂ and [Ir(COD)(dppe)Cl] precursors used in the experiments were synthesised according to published procedures.⁴⁹

**NMR instrumentation.** NMR spectra were recorded using the Bruker Ascend 500 MHz instrument available in the Centre for Hyperpolarization in Magnetic Resonance at York. NMR measurements were carried out using NMR tubes fitted with J. Young's valves. Deuterated solvents were dried using sodium metal. All samples were degassed on a high-vacuum line and the solutions were prepared in a glovebox by the addition of deuterated solvent (0.6 mL) to the solid complexes (~10 mg). Quantitative data for kinetic plots were obtained from the NMR spectra using inverse gated decoupling methods.

**Synthesis of [IrH(1,2,5,6-η²:η²-COD)(dppe)] (2) and [IrH(1-κ-4,5,6-η³-C₈H₁₂)(dppe)] (3).** KO'Bu (77 mg, 0.69 mmol) was added to an isopropanol (10 mL) solution of 1 (100 mg, 0.14 mmol) and stirred at room temperature for 1 hr, generating a cream-coloured solution. The solution was concentrated to dryness, the solid residue was dissolved in toluene (8 mL), and the resulting mixture was passed through an alumina lined pipette. The resulting solution was then concentrated in vacuo. Yield = 98 mg (0.14 mmol, 99 %). This reaction can also be performed using an equivalent amount of NaOMe. ESI-HRMS (m/z relative intensity %): [M-H]⁺ Calcd: 699.1930; Found: 699.1933 (Figure S1). The ¹H NMR analysis of the product
reveals that it contains a mixture of isomers 2 and 3 (see data in Table S3).

**Synthesis of [IrH(1-κ-4,5,6-η³-C₈H₁₀)(dppe)] (4 and 5).** Compound 1 (102 mg, 0.14 mmol) and KO'Bu (71 mg, 0.63 mmol) were added to toluene (15 mL) and the solution was stirred at room temperature for 1 hr, yielding a deep-orange solution. The solvent was then removed *in vacuo*. The orange solid was dissolved in toluene (5 mL) and the resulting mixture was passed through an alumina-lined pipette. The resulting solution was concentrated to dryness. Yield = 40 mg (0.06 mmol, 43 %). ¹H NMR analysis of the product reveals that it contains a mixture of the isomers 4 and 5 (see data in Table S4). **In-situ synthesis of K[IrH₄(dppe)]**. Compound 1 (10 mg, 0.01 mmol), and KO'Bu (7 mg, 0.06 mmol), were added to a solution of isopropanol (0.01 mL) and toluene-d₈ (0.6 mL). The solution was heated to 353 K and NMR spectra were recorded (see Results and Discussion). The formation of K[IrH₄(dppe)] is complete within 30 minutes of heating the mixture. Several attempts were made to isolate the complex as a solid to no avail.

**Computational details.** The computational work undertaken for this study was carried out using the Gaussian09 suite of programs.⁵⁰ Geometry optimizations were carried out without any symmetry constraints using the B3LYP functional⁵¹⁻⁵³ combined with Grimme's D3 correction to account for dispersion effects.⁵⁴ Optimizations were performed in toluene (ε = 2.3741) using the SMD continuum model⁵⁵ with basis set 1 (BS1). BS1 includes the 6-31G(d,p) basis set for the main-group atoms,⁵⁶, ⁵⁷ and the scalar relativistic Stuttgart-Dresden SDD effective core potential (ECP) and its associated double-ζ basis set,⁵⁸ complemented with a set of *f* polarization functions,⁵⁹ for Ir. Frequency calculations were performed for all the optimized geometries in order to characterise the stationary points as either minima or transition states. Connections between the transition states and the corresponding minima were checked by displacing in both directions, following the transition vector, the geometry of the transition states, and subsequent geometry optimization until a minimum was reached. Energies in toluene were refined by means of single-point calculations at the optimised BS1 geometries using an extended basis set (BS2). BS2 consists of the def2-TZVP basis set for the main-group atoms, and the quadruple-ζ def2-QZVP basis set for Ir, together with the def2 ECP (60 core electrons: [Kr]+4d+4f).⁶⁰ Gibbs energies in toluene were calculated adding to the BS2 energies in toluene the thermal and entropic corrections obtained with BS1. An additional correction of 1.9 kcal/mol was applied to all Gibbs energies to change the standard state from the gas phase (1 atm) to the condensed phase (1 M) at 298.15K (ΔG¹atm→¹M).⁶¹ In this way, all the energy values given in the article are Gibbs energies in toluene solution calculated using the formula:

$$G = E(BS2) + G(BS1) - E(BS1) + \Delta G^{1atm \to 1M}$$

## Results and discussion

The interaction between [IrCl(COD)]₂ and dppe, at various P/Ir ratios, in isopropanol solution was investigated sequentially under three different conditions. First, the ligand was added to the complex at room temperature in the absence of a base.

Then, a strong base was added at room temperature. Finally, the resulting solution was heated to reflux.

## [IrCl(COD)]₂-dppe interaction. Formation of [IrCl(COD)(dppe)] (1).

The addition of dppe to [IrCl(COD)]₂ at room temperature, leading to the characterization of a 1:1 adduct, [IrCl(COD)(dppe)], 1, has already been described in the literature.⁴⁹ Single crystals of 1, suitable for X-ray diffraction studies, were obtained and the previously unreported crystal structure is reported here (Figure 1 and Table S1). The coordination geometry is square pyramidal, as expected, and is analogous to that of other similar compounds, e.g. [IrCl(COD)L₂] with L₂ = Ph₂P(CH₂)nPPh₂ (n = 3, 4).⁴⁹

<figure><img src="image_1.png" /><figcaption>Figure 1. A view of the molecular structure of compound 1. Relevant metric data: Ir1-Cl1; 2.5317(8); Ir1-P1, 2.3117(9); Ir1-P2, 2.3072(9); Ir1-C1, 2.211(4); Ir1-C2, 2.177(3); Ir1-C5, 2.147(4); Ir1-C6, 2.142(4) Å; Cl1-Ir1-P1, 90.64(3), Cl1-Ir2-P2, 83.93(3); P1-Ir1-P2, 81.84(3) °.</figcaption></figure>

We have now studied the interaction at variable dppe/Ir ratios (Figure 2). The addition of < 1 equiv of dppe per Ir atom yields, in addition to the expected [IrCl(COD)(dppe)] (³¹P{¹H} resonance at δ 33.4 in C₆D₆), a second product characterized by a resonance at δ 19.5. This second resonance disappears upon addition of further dppe to readjust the dppe/Ir stoichiometry to 1:1. On the basis of the known behaviour for several other bidentate ligands, for instance α-diimines⁶², bis- and tris-pyrazoles,⁶³, ⁶⁴ phosphine-thioethers,⁴² and also for one diphosphine,⁶⁵ this is assigned to the salt [Ir(dppe)(COD)]⁺[IrCl₂(COD)]⁻. Addition of more dppe beyond the 1:1 ratio maintained the sharp ³¹P{¹H} resonance of [IrCl(COD)(dppe)], but also generated an additional resonance at δ 50.0 (in C₆D₆), which we attribute to [IrCl(dppe)]₂ on the basis of the follow-up reaction in the presence of base (vide infra). Compounds of analogous stoichiometry have been described for the reaction between [IrCl(COD)]₂ and excess of other bidentate ligands such as (C₆F₅)₂PCH₂CH₂P(C₆F₅)₂⁶⁶ and a bis(phosphole).⁶⁷
reveals that it contains a mixture of isomers 2 and 3 (see data in Table S3).

**Synthesis of [IrH(1-κ-4,5,6-η³-C₈H₁₀)(dppe)] (4 and 5).**
Compound 1 (102 mg, 0.14 mmol) and KO'Bu (71 mg, 0.63 mmol) were added to toluene (15 mL) and the solution was stirred at room temperature for 1 hr, yielding a deep-orange solution. The solvent was then removed *in vacuo*. The orange solid was dissolved in toluene (5 mL) and the resulting mixture was passed through an alumina-lined pipette. The resulting solution was concentrated to dryness. Yield = 40 mg (0.06 mmol, 43 %). ¹H NMR analysis of the product reveals that it contains a mixture of the isomers 4 and 5 (see data in Table S4). **In-situ synthesis of K[IrH₄(dppe)]**. Compound 1 (10 mg, 0.01 mmol), and KO'Bu (7 mg, 0.06 mmol), were added to a solution of isopropanol (0.01 mL) and toluene-d₈ (0.6 mL). The solution was heated to 353 K and NMR spectra were recorded (see Results and Discussion). The formation of K[IrH₄(dppe)] is complete within 30 minutes of heating the mixture. Several attempts were made to isolate the complex as a solid to no avail.

**Computational details.** The computational work undertaken for this study was carried out using the Gaussian09 suite of programs.⁵⁰ Geometry optimizations were carried out without any symmetry constraints using the B3LYP functional⁵¹⁻⁵³ combined with Grimme's D3 correction to account for dispersion effects.⁵⁴ Optimizations were performed in toluene (ε = 2.3741) using the SMD continuum model⁵⁵ with basis set 1 (BS1). BS1 includes the 6-31G(d,p) basis set for the main-group atoms,⁵⁶, ⁵⁷ and the scalar relativistic Stuttgart-Dresden SDD effective core potential (ECP) and its associated double-ζ basis set,⁵⁸ complemented with a set of *f* polarization functions,⁵⁹ for Ir. Frequency calculations were performed for all the optimized geometries in order to characterise the stationary points as either minima or transition states. Connections between the transition states and the corresponding minima were checked by displacing in both directions, following the transition vector, the geometry of the transition states, and subsequent geometry optimization until a minimum was reached. Energies in toluene were refined by means of single-point calculations at the optimised BS1 geometries using an extended basis set (BS2). BS2 consists of the def2-TZVP basis set for the main-group atoms, and the quadruple-ζ def2-QZVP basis set for Ir, together with the def2 ECP (60 core electrons: [Kr]+4d+4f).⁶⁰ Gibbs energies in toluene were calculated adding to the BS2 energies in toluene the thermal and entropic corrections obtained with BS1. An additional correction of 1.9 kcal/mol was applied to all Gibbs energies to change the standard state from the gas phase (1 atm) to the condensed phase (1 M) at 298.15K (ΔG¹atm→¹M)⁶¹ In this way, all the energy values given in the article are Gibbs energies in toluene solution calculated using the formula:

$$G = E(BS2) + G(BS1) - E(BS1) + \Delta G^{1atm \to 1M}$$

## Results and discussion

The interaction between [IrCl(COD)]₂ and dppe, at various P/Ir ratios, in isopropanol solution was investigated sequentially under three different conditions. First, the ligand was added to the complex at room temperature in the absence of a base.

Then, a strong base was added at room temperature. Finally, the resulting solution was heated to reflux.

## [IrCl(COD)]₂-dppe interaction. Formation of [IrCl(COD)(dppe)] (1).

The addition of dppe to [IrCl(COD)]₂ at room temperature, leading to the characterization of a 1:1 adduct, [IrCl(COD)(dppe)], 1, has already been described in the literature.⁴⁹ Single crystals of 1, suitable for X-ray diffraction studies, were obtained and the previously unreported crystal structure is reported here (Figure 1 and Table S1). The coordination geometry is square pyramidal, as expected, and is analogous to that of other similar compounds, e.g. [IrCl(COD)L₂] with L₂ = Ph₂P(CH₂)nPPh₂ (n = 3, 4).⁴⁹

<figure><img src="image_2.png" /><figcaption>Figure 1. A view of the molecular structure of compound 1. Relevant metric data: Ir1-C1; 2.5317(8); Ir1-P1, 2.3117(9); Ir1-P2, 2.3072(9); Ir1-C1, 2.211(4); Ir1-C2, 2.177(3); Ir1-C5, 2.147(4); Ir1-C6, 2.142(4) Å; Cl1-Ir1-P1, 90.64(3), Cl1-Ir2-P2, 83.93(3); P1-Ir1-P2, 81.84(3) °.</figcaption></figure>

We have now studied the interaction at variable dppe/Ir ratios (Figure 2). The addition of < 1 equiv of dppe per Ir atom yields, in addition to the expected [IrCl(COD)(dppe)] (³¹P{¹H} resonance at δ 33.4 in C₆D₆), a second product characterized by a resonance at δ 19.5. This second resonance disappears upon addition of further dppe to readjust the dppe/Ir stoichiometry to 1:1. On the basis of the known behaviour for several other bidentate ligands, for instance α-diimines⁶², bis- and tris-pyrazoles,⁶³, ⁶⁴ phosphine-thioethers,⁴² and also for one diphosphine,⁶⁵ this is assigned to the salt [Ir(dppe)(COD)]⁺[IrCl₂(COD)]⁻. Addition of more dppe beyond the 1:1 ratio maintained the sharp ³¹P{¹H} resonance of [IrCl(COD)(dppe)], but also generated an additional resonance at δ 50.0 (in C₆D₆), which we attribute to [IrCl(dppe)]₂ on the basis of the follow-up reaction in the presence of base (vide infra). Compounds of analogous stoichiometry have been described for the reaction between [IrCl(COD)]₂ and excess of other bidentate ligands such as (C₆F₅)₂PCH₂CH₂P(C₆F₅)₂⁶⁶ and a bis(phosphole).⁶⁷
ARTICLE

<figure><img src="image_2.png" /><figcaption>Figure 2. ³¹P{$^{1}$H} spectra of solutions obtained by addition of dppe to [IrCl(COD)]$_{2}$ in indicated ratio. Solvent = C$_{6}$D$_{6}$.</figcaption></figure>

## Compound 1 and base at r. t. in isopropanol. Formation of the hydride complexes 2 and 3

The addition of excess base (5 equiv.) at room temperature to a C$_{6}$D$_{6}$ solution with dppe/Ir slightly greater than 1 produced a mixture of thee hydride-dppe compounds (see Figure S2 for the hydride region of the ¹H spectrum and Figure S3 for the ³¹P{$^{1}$H} spectrum, respectively), all of them already reported in the literature. Two of them correspond to a [IrH(COD)(dppe)] stoichiometry and can be assigned the structures [IrH($\eta^{2}$:$\eta^{2}$-1,5-C$_{8}$H$_{12}$)(dppe)], 2,⁶⁸ which is formally Ir¹ and [IrH(1-κ-4,5,6-$\eta^{3}$-C$_{8}$H$_{12}$)(dppe)], 3, which is formally Ir$^{III}$.⁶⁹ The stoichiometry of the reaction leading to the formation of these products is shown in equation 4. The isopropoxide anion is produced by deprotonation of isopropanol by tert-butoxide, the stronger base.

<figure><img src="image_3.png" /></figure>

The third reaction product, observed in minor amounts, corresponds to compound [IrH(dppe)$_{2}$].⁷⁰ It is characterized by a quintet hydride resonance at $\delta$ -12.64 (J$_{HP}$ = 8.7 Hz), coupled to a ³¹P resonance at $\delta$ 36.2. This product is presumably derived directly from the [IrCl(dppe)$_{2}$] that is generated when the dppe/Ir ratio exceeds 1:1 stoichiometry (vide supra). Indeed, it was not formed when the reaction was carried out using a dppe/Ir ratio of slightly less than 1:1. To avoid the formation of this by-product, a toluene solution of 1 was passed through an alumina-lined pipette to remove the bis-dppe species. Crystallization attempts without prior removal of [IrCl(dppe)$_{2}$] led to single crystals of [IrH(dppe)$_{2}$] (Table S2), the structure of which was previously published.⁷¹

The generation of compounds 2 and 3 under conditions similar to ours, as well as that of other related Ir complexes with diphosphinomethane (dppm), diphosphinopropane (dppp), diphosphinobutane (dppb), o-C$_{6}$H$_{4}$(PPh$_{2}$)$_{2}$ and PPh$_{3}$ in place of

dppe, has previously been described.⁴⁸, ⁶⁸, ⁶⁹, ⁷² Some confusion concerning the nature and spectral assignments for these two isomeric products needs clarification (see Table S3). In the first report,⁶⁸ Oro *et al.* obtained [IrH(COD)(dppe)] from the reaction of [Ir(µ-OMe)(COD)]$_{2}$ with dppe in MeOH and described it as an Ir¹ complex containing a regularly $\eta^{2}$:$\eta^{2}$-bonded 1,5-COD ligand, 2, only on the basis of the ¹H NMR properties in CDCl$_{3}$. The compound was mentioned as being unstable in this solvent. We have found a similar instability in CD$_{2}$Cl$_{2}$. The same group later reported that the same reaction carried out with dppm yields instead an Ir$^{III}$ product with an isomerized COD ligand, [IrH(1-κ-4,5,6-$\eta^{3}$-C$_{8}$H$_{12}$)(dppm)], as confirmed by a single crystal X-ray diffraction analysis.⁷² Subsequently, Farnetti *et al.* revisited the same reaction with dppe and found that it produces the same type of rearranged product as Oro's dppm compound, i.e. compound 3.⁶⁹ The NMR properties of this product are different than those reported for 2 by Oro *et al.* and the observation of 2 was not mentioned. In addition, Farnetti *et al.* have shown that the rearrangement is disfavoured for diphosphine ligand with a longer backbone chain, Ph$_{2}$P(CH$_{2}$)$_{n}$PPh$_{2}$ (n = 3, 4): the dppp ligand (n = 3) gave both regular Ir¹ and isomerized Ir$^{III}$ products in an 8:1 ratio and the dppb (n = 4) ligand gave only the regular Ir¹ product, which partially isomerized upon warming.

We find that the addition of excess KO'Bu (5 equiv.) to 1 in iPrOH produces both Ir¹ and Ir$^{III}$ products, presumably via the same type of intermediate as the [Ir(µ-OMe)(COD)]$_{2}$/dppe reaction, namely [Ir(O'Pr)(dppe)(COD)], in a 2/3 ratio of 5:95 at equilibrium at 298 K. The NMR spectral parameters in C$_{6}$D$_{6}$, where the two products appeared perfectly stable, correspond to those reported for the two isomers respectively by Oro *et al.* and by Farnetti *et al.*, although a few of their assignments have been revised (see discussion in the SI following Tale S3) on the basis of detailed multiple resonance and HMQC (H-C, H-P, C-P) experiments (see SI, Figures S4 through S10), and DFT calculations (data also reported in Table S3).

Compound 2 could, however, be selectively generated by an alternative strategy, namely by the low-temperature addition of L-selectride to 1, as confirmed by the ¹H NMR spectrum collected immediately after mixing in THF-d$_{8}$ at 263 K (single triplet hydride resonance at $\delta$ -14.20 with J$_{PH}$ = 21.6 Hz). After 10 minutes, a second hydride peak for the isomer 3 (dd at $\delta$ -11.55 with J$_{PH}$ = 14.7, 20.6 Hz) was observed. Increasing the temperature to 298 K resulted in further isomerization to 3 until a stable equilibrium was reached, where the resonances of 2 remained visible. The isomerization process could be monitored by ¹H NMR during *in situ* generation from 1 and NaOMe in THF-d$_{8}$ at constant temperature (298 K), with resonance integration, see Figure 3. Kinetic analysis as a sequential process with irreversible first-order transformation of 1 to 2 followed by first-order reversible transformation of 2 to 3, as detailed in the SI, yielded k$_{12}$ = (1.11±0.02)·10⁻⁴ s⁻¹; k$_{23}$ = (3.4±0.2)·10⁻⁴ s⁻¹ and k$_{32}$ = (1.1±0.3)·10⁻⁵ s⁻¹ (K$_{23}$ = k$_{23}$/k$_{32}$ = 32±10). The decay of compound 1 could also be treated independently as a clean first order process (Figure S11), yielding k$_{12}$ = (1.13±0.03)·10⁻⁴ s⁻¹, in agreement with the value obtained from the global fit.

<figure><img src="image_4.png" /></figure>

Dalton Transactions Accepted Manuscript
ARTICLE

<figure><img src="image_3.png" /><figcaption>Figure 2. ³¹P{$^{1}$H} spectra of solutions obtained by addition of dppe to [IrCl(COD)]₂ in indicated ratio. Solvent = C₆D₆.</figcaption></figure>

## Compound 1 and base at r. t. in isopropanol. Formation of the hydride complexes 2 and 3

The addition of excess base (5 equiv.) at room temperature to a C₆D₆ solution with dppe/Ir slightly greater than 1 produced a mixture of thee hydride-dppe compounds (see Figure S2 for the hydride region of the ¹H spectrum and Figure S3 for the ³¹P{$^{1}$H} spectrum, respectively), all of them already reported in the literature. Two of them correspond to a [IrH(COD)(dppe)] stoichiometry and can be assigned the structures [IrH(η²:η²-1,5-C₈H₁₂)(dppe)], 2,⁶⁸ which is formally Ir¹ and [IrH(1-κ-4,5,6-η³-C₈H₁₂)(dppe)], 3, which is formally IrΠ.⁶⁹ The stoichiometry of the reaction leading to the formation of these products is shown in equation 4. The isopropoxide anion is produced by deprotonation of isopropanol by tert-butoxide, the stronger base.

<figure><img src="image_4.png" /></figure>

The third reaction product, observed in minor amounts, corresponds to compound [IrH(dppe)₂].⁷⁰ It is characterized by a quintet hydride resonance at δ -12.64 (J<sub>HP</sub> = 8.7 Hz), coupled to a ³¹P resonance at δ 36.2. This product is presumably derived directly from the [IrCl(dppe)₂] that is generated when the dppe/Ir ratio exceeds 1:1 stoichiometry (vide supra). Indeed, it was not formed when the reaction was carried out using a dppe/Ir ratio of slightly less than 1:1. To avoid the formation of this by-product, a toluene solution of 1 was passed through an alumina-lined pipette to remove the bis-dppe species. Crystallization attempts without prior removal of [IrCl(dppe)₂] led to single crystals of [IrH(dppe)₂] (Table S2), the structure of which was previously published.⁷¹

The generation of compounds 2 and 3 under conditions similar to ours, as well as that of other related Ir complexes with diphosphinomethane (dppm), diphosphinopropane (dppp), diphosphinobutane (dppb), o-C₆H₄(PPh₂)₂ and PPh₃ in place of

dppe, has previously been described.⁴⁸, ⁶⁸, ⁶⁹, ⁷² Some confusion concerning the nature and spectral assignments for these two isomeric products needs clarification (see Table S3). In the first report,⁶⁸ Oro *et al.* obtained [IrH(COD)(dppe)] from the reaction of [Ir(μ-OMe)(COD)]₂ with dppe in MeOH and described it as an Ir¹ complex containing a regularly η²:η²-bonded 1,5-COD ligand, 2, only on the basis of the ¹H NMR properties in CDCl₃. The compound was mentioned as being unstable in this solvent. We have found a similar instability in CD₂Cl₂. The same group later reported that the same reaction carried out with dppm yields instead an IrΠ product with an isomerized COD ligand, [IrH(1-κ-4,5,6-η³-C₈H₁₂)(dppm)], as confirmed by a single crystal X-ray diffraction analysis.⁷² Subsequently, Farnetti *et al.* revisited the same reaction with dppe and found that it produces the same type of rearranged product as Oro's dppm compound, i.e. compound 3.⁶⁹ The NMR properties of this product are different than those reported for 2 by Oro *et al.* and the observation of 2 was not mentioned. In addition, Farnetti *et al.* have shown that the rearrangement is disfavoured for diphosphine ligand with a longer backbone chain, Ph₂P(CH₂)₆PPh₂ (n = 3, 4): the dppp ligand (n = 3) gave both regular Ir¹ and isomerized IrΠ products in an 8:1 ratio and the dppb (n = 4) ligand gave only the regular Ir¹ product, which partially isomerized upon warming.

We find that the addition of excess KO⁺Bu (5 equiv.) to 1 in iPrOH produces both Ir¹ and IrΠ products, presumably via the same type of intermediate as the [Ir(μ-OMe)(COD)]₂/dppe reaction, namely [Ir(O'Pr)(dppe)(COD)], in a 2/3 ratio of 5:95 at equilibrium at 298 K. The NMR spectral parameters in C₆D₆, where the two products appeared perfectly stable, correspond to those reported for the two isomers respectively by Oro *et al.* and by Farnetti *et al.*, although a few of their assignments have been revised (see discussion in the SI following Tale S3) on the basis of detailed multiple resonance and HMQC (H-C, H-P, C-P) experiments (see SI, Figures S4 through S10), and DFT calculations (data also reported in Table S3).

Compound 2 could, however, be selectively generated by an alternative strategy, namely by the low-temperature addition of L-selectride to 1, as confirmed by the ¹H NMR spectrum collected immediately after mixing in THF-d₈ at 263 K (single triplet hydride resonance at δ -14.20 with J<sub>PH</sub> = 21.6 Hz). After 10 minutes, a second hydride peak for the isomer 3 (dd at δ -11.55 with J<sub>PH</sub> = 14.7, 20.6 Hz) was observed. Increasing the temperature to 298 K resulted in further isomerization to 3 until a stable equilibrium was reached, where the resonances of 2 remained visible. The isomerization process could be monitored by ¹H NMR during *in situ* generation from 1 and NaOMe in THF-d₈ at constant temperature (298 K), with resonance integration, see Figure 3. Kinetic analysis as a sequential process with irreversible first-order transformation of 1 to 2 followed by first-order reversible transformation of 2 to 3, as detailed in the SI, yielded k₁₂ = (1.11±0.02)·10⁻⁴ s⁻¹; k₂₃ = (3.4±0.2)·10⁻⁴ s⁻¹ and k₃₂ = (1.1±0.3)·10⁻⁵ s⁻¹ (K₂₃ = k₂₃/k₃₂ = 32±10). The decay of compound 1 could also be treated independently as a clean first order process (Figure S11), yielding k₁₂ = (1.13±0.03)·10⁻⁴ s⁻¹, in agreement with the value obtained from the global fit.

Dalton Transactions Accepted Manuscript
<figure><img src="image_5.png" /><figcaption>Figure 3. Time evolution of the ³¹P({¹H} data for 1 decay and 2-3 isomerization. The continuous lines are the result of the non-linear least-squares fit as described in the SI.</figcaption></figure>

A DFT investigation was carried out, without any structural simplification (see Computational Details), to establish the mechanism of the isomerization process. The results are summarized in Figure 4. The investigation started with the optimization of the two isomers **2** and **3**, finding greater stability for **3** by 3.5 kcal mol⁻¹ relative to **2**. This is in good agreement with the experimental equilibrium, which returns a Gibbs energy difference of 2.06±0.16 kcal mol⁻¹ in favour of **3** by application of van't Hoff's equation. The optimized structure of **2** is trigonal bipyramidal with the hydride and one of the COD double bonds occupying the axial positions, whereas that of **3** is best described as derived from an octahedron, with a *fac* arrangement of the hydride and the two P donors and with the 1-κ-C donor *trans* to one of the two P donors, rendering the two P nuclei inequivalent, which agrees with the NMR data. This ligand arrangement is identical to that observed by X-ray diffraction for the analogous dppm derivative.⁷² An alternative structural isomer for **3** with the 1-κ-C donor *trans* to the hydride, which would be symmetrical with magnetically equivalent P nuclei, is located 6.8 kcal mol⁻¹ higher in Gibbs energy. It is probably disfavoured by the placement of two strong σ-donors (the hydride and the 1-κ-C atom) *trans* to each other.

<figure><img src="image_6.png" /><figcaption>Figure 4. Gibbs energy profile (in kcal mol⁻¹) for the isomerization of **2** to **3**</figcaption></figure>

A reasonable working hypothesis for this isomerization consists of a two-step process, proceeding *via* the 16-electron 1-κ-4,5-η²-cyclooctenyl intermediate, [Ir(1-κ-4,5-η²-C₈H₁₃)(dppe)] (I), of Scheme 1. DFT calculations could optimize the geometry of this intermediate, which is square-planar as expected, and of the two transition states relating I to **2** (TS₂-I) and to **3** (TS₁-3), see Figure 4. The Ir-H distance lengthens and the C-H distance to the appropriate C atom shortens going from **2** and from **3** to the transition state leading to I. The highest free-energy transition state is TS₁-3, located at 19.8 kcal mol⁻¹ from **2** (23.3 kcal mol⁻¹ from **3**). This value agrees well with the experimentally determined barrier (ΔG₂-3‡ = 22.19±0.04 kcal mol⁻¹ by application of the Eyring equation). Thus, in kinetic terms, the 2/I step is a pre-equilibrium, preceding the rate-determining conversion of I to **3**. The Gibbs energy of I is computed as 1.3 kcal mol⁻¹ higher than that of **2**, which is consistent with the fact that it is not observed by either ¹H or ³¹P({¹H} NMR during the isomerization monitoring.

<figure><img src="image_7.png" /><figcaption>Scheme 1. Reaction coordinate for the isomerization of **2** to **3** (dppe omitted for clarity)</figcaption></figure>

### Reaction between Compound 1 and KO¹Bu at room temperature in toluene. Formation of the hydride complexes 4 and 5

When KO¹Bu was added to **1** in C₆D₆ or THF-d₈ in the absence of isopropanol, a rapid reaction takes place. The ¹H NMR spectrum in THF-d₈ at 263K recorded immediately after addition of the base showed the generation of two new isomeric hydride complexes (**4** and **5**) in an 86:14 ratio, subsequently evolving to an equilibrium position where **5** slightly predominates (32:68), see Figure S12. The NMR properties of these two compounds are summarized in Table S4. Resonances for complexes **2** and **3** described above were not observed in this experiment, see Figures S13-S15.

The hydride resonance of **4** is a doublet of doublets at δ -11.43 ($J_{PH}$ = 14.1, 21.8 Hz), correlating with two resonances at δ 30.6 (d, $J_{PP}$ = 2.4 Hz), and δ 46.7 (d, $J_{PP}$ = 2.4 Hz) in the ³¹P({¹H} NMR spectrum. Two broad peaks at δ 5.94 and δ 5.47 appear for an unbound olefin moiety, confirmed by connections to two ¹³C signals at δ 130.0 and δ 127.7, respectively (Figure S15).

Three additional resonances in the alkene region of the ¹H NMR spectrum suggest a cyclooctatriene ligand coordinating through η³ and κ¹ interactions, [IrH(1-κ-4,5,6-η³-C₈H₁₀)(dppe)] (**4**), as confirmed by NOE interactions between the CH₂ fragments and the alkene CH groups (see Figure S18). Hence, the reaction consists of the elimination of HCl from **1** *via* the initial deprotonation of one COD C-H bond, chloride dissociation and transfer of a second COD H atom to the metal centre as a hydride ligand (Scheme 2). The σ CH donor is located *trans* to one of the P donor atoms and the κ³ moiety is *trans* to the second phosphine and the hydride, with the uncoordinated double bond placed in the equatorial plane.
<figure><img src="image_5.png" /><figcaption>Figure 3. Time evolution of the ³¹P({¹H} data for 1 decay and 2-3 isomerization. The continuous lines are the result of the non-linear least-squares fit as described in the SI.</figcaption></figure>

A DFT investigation was carried out, without any structural simplification (see Computational Details), to establish the mechanism of the isomerization process. The results are summarized in Figure 4. The investigation started with the optimization of the two isomers **2** and **3**, finding greater stability for **3** by 3.5 kcal mol⁻¹ relative to **2**. This is in good agreement with the experimental equilibrium, which returns a Gibbs energy difference of 2.06±0.16 kcal mol⁻¹ in favour of **3** by application of van't Hoff's equation. The optimized structure of **2** is trigonal bipyramidal with the hydride and one of the COD double bonds occupying the axial positions, whereas that of **3** is best described as derived from an octahedron, with a *fac* arrangement of the hydride and the two P donors and with the 1-κ-C donor *trans* to one of the two P donors, rendering the two P nuclei inequivalent, which agrees with the NMR data. This ligand arrangement is identical to that observed by X-ray diffraction for the analogous dppm derivative.⁷² An alternative structural isomer for **3** with the 1-κ-C donor *trans* to the hydride, which would be symmetrical with magnetically equivalent P nuclei, is located 6.8 kcal mol⁻¹ higher in Gibbs energy. It is probably disfavoured by the placement of two strong σ-donors (the hydride and the 1-κ-C atom) *trans* to each other.

<figure><img src="image_6.png" /><figcaption>Figure 4. Gibbs energy profile (in kcal mol⁻¹) for the isomerization of **2** to **3**</figcaption></figure>

A reasonable working hypothesis for this isomerization consists of a two-step process, proceeding *via* the 16-electron 1-κ-4,5-η²-cyclooctenyl intermediate, [Ir(1-κ-4,5-η²-C₈H₁₃)(dppe)] (I), of Scheme 1. DFT calculations could optimize the geometry of this intermediate, which is square-planar as expected, and of the two transition states relating I to **2** (TS₂-I) and to **3** (TS₁-3), see Figure 4. The Ir-H distance lengthens and the C-H distance to the appropriate C atom shortens going from **2** and from **3** to the transition state leading to I. The highest free-energy transition state is TS₁-3, located at 19.8 kcal mol⁻¹ from **2** (23.3 kcal mol⁻¹ from **3**). This value agrees well with the experimentally determined barrier (ΔG₂-3‡ = 22.19±0.04 kcal mol⁻¹ by application of the Eyring equation). Thus, in kinetic terms, the 2/I step is a pre-equilibrium, preceding the rate-determining conversion of I to **3**. The Gibbs energy of I is computed as 1.3 kcal mol⁻¹ higher than that of **2**, which is consistent with the fact that it is not observed by either ¹H or ³¹P({¹H} NMR during the isomerization monitoring.

<figure><img src="image_7.png" /><figcaption>Scheme 1. Reaction coordinate for the isomerization of **2** to **3** (dppe omitted for clarity)</figcaption></figure>

### Reaction between Compound 1 and KO¹Bu at room temperature in toluene. Formation of the hydride complexes 4 and 5

When KO¹Bu was added to **1** in C₆D₆ or THF-d₈ in the absence of isopropanol, a rapid reaction takes place. The ¹H NMR spectrum in THF-d₈ at 263K recorded immediately after addition of the base showed the generation of two new isomeric hydride complexes (**4** and **5**) in an 86:14 ratio, subsequently evolving to an equilibrium position where **5** slightly predominates (32:68), see Figure S12. The NMR properties of these two compounds are summarized in Table S4. Resonances for complexes **2** and **3** described above were not observed in this experiment, see Figures S13-S15.

The hydride resonance of **4** is a doublet of doublets at δ -11.43 (J<sub>PH</sub> = 14.1, 21.8 Hz), correlating with two resonances at δ 30.6 (d, J<sub>PP</sub> = 2.4 Hz), and δ 46.7 (d, J<sub>PP</sub> = 2.4 Hz) in the ³¹P({¹H} NMR spectrum. Two broad peaks at δ 5.94 and δ 5.47 appear for an unbound olefin moiety, confirmed by connections to two ¹³C signals at δ 130.0 and δ 127.7, respectively (Figure S15).

Three additional resonances in the alkene region of the ¹H NMR spectrum suggest a cyclooctatriene ligand coordinating through η³ and κ¹ interactions, [IrH(1-κ-4,5,6-η³-C₈H₁₀)(dppe)] (**4**), as confirmed by NOE interactions between the CH₂ fragments and the alkene CH groups (see Figure S18). Hence, the reaction consists of the elimination of HCl from **1** *via* the initial deprotonation of one COD C-H bond, chloride dissociation and transfer of a second COD H atom to the metal centre as a hydride ligand (Scheme 2). The σ CH donor is located *trans* to one of the P donor atoms and the κ³ moiety is *trans* to the second phosphine and the hydride, with the uncoordinated double bond placed in the equatorial plane.

Dalton Transactions Accepted Manuscript
ARTICLE

<figure><img src="image_8.png" /><figcaption>Scheme 2. Direct deprotonation of the COD on **1** occurs in the absence of isopropanol.</figcaption></figure>

Compound **5** is characterized by a hydride resonance at δ -11.57 (t, *J*<sub>PH</sub> = 19.5 Hz), which is coupled to two <sup>31</sup>P resonances at δ 32.4 (d, *J*<sub>PP</sub> = 2.7 Hz) and 39.4 (d, *J*<sub>PP</sub> = 2.7 Hz). It is an isomer of **4** with the same coordination geometry, [IrH(1-κ-4,5,6-η<sup>3</sup>-C<sub>8</sub>H<sub>10</sub>)(dppe)], except that the saturated ethylene bridge and uncoordinated alkene have exchanged position. This isomer exhibits resonances for an unbound alkene at δ 5.61 and δ 5.56 with connections to <sup>13</sup>C signals at δ 127.5 and δ 148.1 (Figure S15). The 1-κ-4,5,6-η<sup>3</sup> binding mode for a C<sub>8</sub>H<sub>10</sub> ligand was also previously demonstrated for the structurally characterized complex [IrH(1-κ-4,5,6-η<sup>3</sup>-C<sub>8</sub>H<sub>10</sub>)(dppb)],<sup>73</sup> which is homologous with complex **4**.

The process depicted in Scheme 2 was also analysed kinetically
in C<sub>6</sub>D<sub>6</sub> at 298 K. Unlike the production and isomerization of **2/3**
shown in Figure 3, the consumption of **1** was a rapid first step,
allowing clean timescale separation of the two steps and
analysis of the second step as a standard reversible first-order
reaction (Figure 5), yielding k<sub>45</sub> = (2.75±0.06)·10<sup>-4</sup> s<sup>-1</sup> and k<sub>54</sub> =
(1.16±0.08)·10<sup>-4</sup> s<sup>-1</sup>; K<sub>45</sub> = k<sub>45</sub>/k<sub>54</sub> = 2.37±0.17. A separate kinetic
monitoring in toluene-d<sub>8</sub> (Figure S19) gave very similar rate and
equilibrium parameters, with k<sub>45</sub> = (3.92±0.11)·10<sup>-4</sup> s<sup>-1</sup>, k<sub>5.4</sub> =
(1.39±0.12)·10<sup>-4</sup> s<sup>-1</sup> and K<sub>45</sub> = k<sub>45</sub>/k<sub>54</sub> = 2.83±0.26.

<figure><img src="image_9.png" /><figcaption>Figure 5. First-order kinetics of the **4-5** isomerization in C<sub>6</sub>D<sub>6</sub> at 298 K.</figcaption></figure>

The identity and relative energy of the two [IrH(1-κ-4,5,6-η³-C₈H₁₀)(dppe)] isomers **4** and **5** was supported by DFT calculations, which could also rationalize the selective formation of **4** by deprotonation, and the mechanism of its conversion to **5**. As illustrated in Scheme 3, the deprotonation of **1** is expected to produce, after chloride elimination, a neutral 16-electron [Ir(C₈H₁₁)(dppe)] intermediate. Four possibilities may be envisaged, two corresponding to a [Ir(1-κ-6,7-η²-C₈H₁₁)(dppe)] structure (II and II') and two corresponding to a

[Ir(η³-C₈H₁₁)(dppe)] structure (II" and II"'). Each pair of structures corresponds to the dissociation of a different C=C donor function in the COD ligand of **1** and the two conformers in each pair differ in the orientation of the dppe ligand ('flip' or 'flop' conformation of the IrP₂C₂ 5-membered ring) relative to the C₈H₁₁ ligand. The lowest energy was found for conformer II, with II' being located only 0.9 kcal mol⁻¹ above. The η³ isomer III' is located at 3.7 kcal mol⁻¹ and III'' was not explored. These intermediates may then proceed to a hydride-C₈H₁₀ product by β-H elimination.

<figure><img src="image_10.png" /><figcaption>Scheme 3. Reaction scheme for the generation of **4**. The phenyl groups on the dppe are omitted for clarity. (V: 5.8; VI: 4.9; VII: 9.7).</figcaption></figure>

Starting from II or II', the hydride may originate from carbons 4, 5 and 8 to yield in principle three different regioisomers, each one in a flip or flop conformation (Scheme 3). Two of them (unobserved), generated by H transfer from C4 and C5, have two separate methylene groups either between unsaturated C2 and C4 moieties (1,3,6-COT; III and III') or between two unsaturated C3 moieties (1-κ-5,6,7-η³-C₈H₁₀; IV and IV'). The configurations produced by H transfer from C8 (4 and 4') match the structure observed by NMR. Exploration of all three pathways for II (Figure 6) and II' (Figure S20) showed that the β-H8 eliminations are associated with the lowest-G transition states (22.5 kcal mol⁻¹ for TS<sub>II-4</sub>, 20.8 kcal mol⁻¹ for TS<sub>II-4'</sub>) and yield the most stable products. The other pathways involve higher-energy transition states and yield higher energy hydride complexes, justifying their non-observation. Among the two conformers 4 and 4', the former is more stable (-1.8 Kcal mol⁻¹ relative to II) while the latter (at 1.5 kcal mol⁻¹) is accessed from
ARTICLE

<figure><img src="image_8.png" /><figcaption>Scheme 2. Direct deprotonation of the COD on **1** occurs in the absence of isopropanol.</figcaption></figure>

Compound **5** is characterized by a hydride resonance at δ -11.57 (t, *J*<sub>PH</sub> = 19.5 Hz), which is coupled to two <sup>31</sup>P resonances at δ 32.4 (d, *J*<sub>PP</sub> = 2.7 Hz) and 39.4 (d, *J*<sub>PP</sub> = 2.7 Hz). It is an isomer of **4** with the same coordination geometry, [IrH(1-κ-4,5,6-η<sup>3</sup>-C<sub>8</sub>H<sub>10</sub>)(dppe)], except that the saturated ethylene bridge and uncoordinated alkene have exchanged position. This isomer exhibits resonances for an unbound alkene at δ 5.61 and δ 5.56 with connections to <sup>13</sup>C signals at δ 127.5 and δ 148.1 (Figure S15). The 1-κ-4,5,6-η<sup>3</sup> binding mode for a C<sub>8</sub>H<sub>10</sub> ligand was also previously demonstrated for the structurally characterized complex [IrH(1-κ-4,5,6-η<sup>3</sup>-C<sub>8</sub>H<sub>10</sub>)(dppb)],<sup>73</sup> which is homologous with complex **4**.

The process depicted in Scheme 2 was also analysed kinetically
in C<sub>6</sub>D<sub>6</sub> at 298 K. Unlike the production and isomerization of **2/3**
shown in Figure 3, the consumption of **1** was a rapid first step,
allowing clean timescale separation of the two steps and
analysis of the second step as a standard reversible first-order
reaction (Figure 5), yielding k<sub>45</sub> = (2.75±0.06)·10<sup>-4</sup> s<sup>-1</sup> and k<sub>54</sub> =
(1.16±0.08)·10<sup>-4</sup> s<sup>-1</sup>; K<sub>45</sub> = k<sub>45</sub>/k<sub>54</sub> = 2.37±0.17. A separate kinetic
monitoring in toluene-d<sub>8</sub> (Figure S19) gave very similar rate and
equilibrium parameters, with k<sub>45</sub> = (3.92±0.11)·10<sup>-4</sup> s<sup>-1</sup>, k<sub>54</sub> =
(1.39±0.12)·10<sup>-4</sup> s<sup>-1</sup> and K<sub>45</sub> = k<sub>45</sub>/k<sub>54</sub> = 2.83±0.26.

<figure><img src="image_9.png" /><figcaption>Figure 5. First-order kinetics of the **4-5** isomerization in C<sub>6</sub>D<sub>6</sub> at 298 K.</figcaption></figure>

The identity and relative energy of the two [IrH(1-κ-4,5,6-η³-C₈H₁₀)(dppe)] isomers **4** and **5** was supported by DFT calculations, which could also rationalize the selective formation of **4** by deprotonation, and the mechanism of its conversion to **5**. As illustrated in Scheme 3, the deprotonation of **1** is expected to produce, after chloride elimination, a neutral 16-electron [Ir(C₈H₁₁)(dppe)] intermediate. Four possibilities may be envisaged, two corresponding to a [Ir(1-κ-6,7-η²-C₈H₁₁)(dppe)] structure (II and II') and two corresponding to a

[Ir(η³-C₈H₁₁)(dppe)] structure (II" and II"'). Each pair of structures corresponds to the dissociation of a different C=C donor function in the COD ligand of **1** and the two conformers in each pair differ in the orientation of the dppe ligand ('flip' or 'flop' conformation of the IrP₂C₂ 5-membered ring) relative to the C₈H₁₁ ligand. The lowest energy was found for conformer II, with II' being located only 0.9 kcal mol⁻¹ above. The η³ isomer III' is located at 3.7 kcal mol⁻¹ and III'' was not explored. These intermediates may then proceed to a hydride-C₈H₁₀ product by β-H elimination.

<figure><img src="image_10.png" /><figcaption>Scheme 3. Reaction scheme for the generation of **4**. The phenyl groups on the dppe are omitted for clarity. (V: 5.8; VI: 4.9; VII: 9.7).</figcaption></figure>

Starting from **II** or **II'**, the hydride may originate from carbons 4, 5 and 8 to yield in principle three different regioisomers, each one in a flip or flop conformation (Scheme 3). Two of them (unobserved), generated by H transfer from C4 and C5, have two separate methylene groups either between unsaturated C2 and C4 moieties (1,3,6-COT; **III** and **III'**) or between two unsaturated C3 moieties (1-κ-5,6,7-η³-C₈H₁₀; **IV** and **IV'**). The configurations produced by H transfer from C8 (4 and 4') match the structure observed by NMR. Exploration of all three pathways for **II** (Figure 6) and **II'** (Figure S20) showed that the β-H8 eliminations are associated with the lowest-G transition states (22.5 kcal mol⁻¹ for **TS**<sub>II-4</sub>, 20.8 kcal mol⁻¹ for **TS**<sub>II-4'</sub>) and yield the most stable products. The other pathways involve higher-energy transition states and yield higher energy hydride complexes, justifying their non-observation. Among the two conformers 4 and 4', the former is more stable (-1.8 Kcal mol⁻¹ relative to II) while the latter (at 1.5 kcal mol⁻¹) is accessed from

Dai
on
Tr
ans
ac
ed
Ma
nu
script
the higher-energy II' through a lower barrier. We presume that
the barrier for the flip-flop conformational change is even
lower, thus the two conformers are at rapid equilibrium on the
NMR timescale and only one set of signals is observed.

The β-H elimination process from II'' and II''' may in principle
occur from carbons 4, 7 and 8. The β-elimination of H4 may lead
again, upon rearrangement of the C4-C5-C6 electron density, to
4 and 4', or directly to the new isomers V and V', in which the
COT ligand binds as a conjugated η⁴ diene. The elimination of
H7 leads to VI and VI', in which the ligand is bonded to the Ir
atom as in IV and IV' but is oriented differently with respect to
the H and dppe ligands. Finally, the elimination of H8 leads to
another two configurations (VII and VII') with a 1,3,6-COT ligand
bonded as a conjugated η⁴ diene., like III and III' but in a
different orientation. The geometries of V, VI and VII were
optimized and found again at higher energies (5.8, 4.9 and 9.7
kcal mol⁻¹, respectively) with respect to II. Therefore, these
processes were not further explored.

Note how the lowest-energy product obtained from **II** (4) features the uncoordinated alkene moiety syn relative to the hydride ligand. No direct pathway is available to transform intermediate **II** to isomer **5**, for which, on the other hand, the uncoordinated alkene moiety is located *trans* relative to the hydride ligand. Note also that the higher *G* value of intermediate **II** relative to **4** agrees with its non-observation.

The isomerization of **4** to **5** then proceeds *via* the rearrangement schematically illustrated in Figure 7. This entails a rotation of the C<sub>8</sub>H<sub>10</sub> ligand relative to the Ir-H axis via TS<sub>4-5'</sub> with simultaneous displacement toward the Ir atom of the two CH groups of the uncoordinated alkene, which become part of the coordinated η<sup>3</sup> moiety, and the inverse displacement of the two CH groups of the coordinated η<sup>3</sup> moiety that end up forming the uncoordinated alkene moiety. This process, which is rate-determining, has a calculated barrier of 24.0 kcal mol<sup>-1</sup> from **4**, quite close to that obtained from the measured rate constant k<sub>4-5</sub> by application of the Eyring relationship (22.3±0.1 kcal mol<sup>-1</sup>). The product of this rearrangement, however, is a higher-energy flip-flop conformer (5') of the most stable

Of particular interest is the fact that the ligand prefers to adopt
a 1-κ-4,5,6-η³-C₈H₁₀ geometry with an uncoordinated C2-C3
double bond in both **4** and **5**, hence yielding two formally Ir III
isomers, rather than an 18-electron 1,3,5-COT structure
resulting in a formally Ir¹ 18-electron complex (the optimized
higher-energy **V**). There are literature precedents for the
1,2,5,6-η²,η² binding mode of COT in iridium chemistry, for
instance [IrCl(COT)]₂ and Cplr(COT),⁷⁴ although none has been
structurally characterized to the best of our knowledge.
Structures featuring this type of COT coordination are, however,
available for Co',⁷⁵ Mo⁰,⁷⁶ and Ru⁰.⁷⁷⁻⁷⁹

Concerning the 1-κ-4,5,6-η³ binding mode, as already mentioned above, this is documented for the homologous complex [IrH(1-κ-4,5,6-η-C₈H₁₀)(dppb)]<sub>2</sub>,<sup>73</sup> which was obtained by addition of dppb to [Ir(NH<sub>2</sub>)(COD)]<sub>2</sub>. However, the presence of more than one isomer was not mentioned in that contribution. That reaction is closely related to ours, because a bridging amido ligand serves as an internal base to deprotonate the COD ligand with elimination of ammonia.<sup>73</sup> Thus, the action of a strong base on the COD ligand in compound **1**, in the absence of more acidic reagents such as isopropanol that can themselves be deprotonated, coordinate to the metal and then

geometry for 5. The conformational flip-flop rearrangement can
probably occur through a small barrier. We could also find,
however, an alternative pathway, *via* the electronic
rearrangement of the C<sub>8</sub>H<sub>10</sub> ligand, as illustrated in Figure 7. The
transition state for this process is located at a relatively low G
(10.3 Kcal mol<sup>-1</sup>). Therefore, 5' converts to the more stable
structure 5 very rapidly and the two conformers are expected
to be in rapid equilibrium on the NMR timescale at room
temperature. The calculated energy difference between 5 and
4 (-0.5 kcal mol<sup>-1</sup>) agrees with the experimental value of -
0.51±0.04 kcal mol<sup>-1</sup> in benzene (or -0.62±0.06 kcal mol<sup>-1</sup> in
toluene).

<figure><img src="image_11.png" /><figcaption>Figure 6. Gibbs-energy profile (in kcal mol⁻¹) for all possible β-H elimination reactions from intermediate II.</figcaption></figure>

<figure><img src="image_12.png" /><figcaption>Figure 7. Gibbs-energy profile (in kcal mol⁻¹) for the isomerisation of **4** to **5** by electronic rearrangement of the (1-κ-4,5,6-η³-C₈H₁₀) ligand.</figcaption></figure>

Dai
non
Trans
ac
Man
schrift
the higher-energy II' through a lower barrier. We presume that
the barrier for the flip-flop conformational change is even
lower, thus the two conformers are at rapid equilibrium on the
NMR timescale and only one set of signals is observed.

The β-H elimination process from II'' and II''' may in principle
occur from carbons 4, 7 and 8. The β-elimination of H4 may lead
again, upon rearrangement of the C4-C5-C6 electron density, to
4 and 4', or directly to the new isomers V and V', in which the
COT ligand binds as a conjugated η⁴ diene. The elimination of
H7 leads to VI and VI', in which the ligand is bonded to the Ir
atom as in IV and IV' but is oriented differently with respect to
the H and dppe ligands. Finally, the elimination of H8 leads to
another two configurations (VII and VII') with a 1,3,6-COT ligand
bonded as a conjugated η⁴ diene., like III and III' but in a
different orientation. The geometries of V, VI and VII were
optimized and found again at higher energies (5.8, 4.9 and 9.7
kcal mol⁻¹, respectively) with respect to II. Therefore, these
processes were not further explored.

Note how the lowest-energy product obtained from **II** (4) features the uncoordinated alkene moiety syn relative to the hydride ligand. No direct pathway is available to transform intermediate **II** to isomer **5**, for which, on the other hand, the uncoordinated alkene moiety is located *trans* relative to the hydride ligand. Note also that the higher *G* value of intermediate **II** relative to **4** agrees with its non-observation.

The isomerization of **4** to **5** then proceeds *via* the rearrangement schematically illustrated in Figure 7. This entails a rotation of the C<sub>8</sub>H<sub>10</sub> ligand relative to the Ir-H axis via TS<sub>4-5'</sub> with simultaneous displacement toward the Ir atom of the two CH groups of the uncoordinated alkene, which become part of the coordinated η<sup>3</sup> moiety, and the inverse displacement of the two CH groups of the coordinated η<sup>3</sup> moiety that end up forming the uncoordinated alkene moiety. This process, which is rate-determining, has a calculated barrier of 24.0 kcal mol<sup>-1</sup> from **4**, quite close to that obtained from the measured rate constant k<sub>4-5</sub> by application of the Eyring relationship (22.3±0.1 kcal mol<sup>-1</sup>). The product of this rearrangement, however, is a higher-energy flip-flop conformer (5') of the most stable

geometry for 5. The conformational flip-flop rearrangement can
probably occur through a small barrier. We could also find,
however, an alternative pathway, *via* the electronic
rearrangement of the C<sub>8</sub>H<sub>10</sub> ligand, as illustrated in Figure 7. The
transition state for this process is located at a relatively low G
(10.3 Kcal mol<sup>-1</sup>). Therefore, 5' converts to the more stable
structure 5 very rapidly and the two conformers are expected
to be in rapid equilibrium on the NMR timescale at room
temperature. The calculated energy difference between 5 and
4 (-0.5 kcal mol<sup>-1</sup>) agrees with the experimental value of -
0.51±0.04 kcal mol<sup>-1</sup> in benzene (or -0.62±0.06 kcal mol<sup>-1</sup> in
toluene).

<figure><img src="image_11.png" /><figcaption>Figure 6. Gibbs-energy profile (in kcal mol⁻¹) for all possible β-H elimination reactions from intermediate II.</figcaption></figure>

Of particular interest is the fact that the ligand prefers to adopt
a 1-κ-4,5,6-η³-C₈H₁₀ geometry with an uncoordinated C2-C3
double bond in both **4** and **5**, hence yielding two formally Ir III
isomers, rather than an 18-electron 1,3,5-COT structure
resulting in a formally Ir I 18-electron complex (the optimized
higher-energy **V**). There are literature precedents for the
1,2,5,6-η²,η² binding mode of COT in iridium chemistry, for
instance [IrCl(COT)]₂ and Cplr(COT),⁷⁴ although none has been
structurally characterized to the best of our knowledge.
Structures featuring this type of COT coordination are, however,
available for Co',⁷⁵ Mo⁰,⁷⁶ and Ru⁰.⁷⁷⁻⁷⁹

Concerning the 1-κ-4,5,6-η³ binding mode, as already
mentioned above, this is documented for the homologous
complex [IrH(1-κ-4,5,6-η-C₈H₁₀)(dppb)]<sub>2</sub>,<sup>73</sup> which was obtained
by addition of dppb to [Ir(NH<sub>2</sub>)(COD)]<sub>2</sub>. However, the presence
of more than one isomer was not mentioned in that
contribution. That reaction is closely related to ours, because a
bridging amido ligand serves as an internal base to deprotonate
the COD ligand with elimination of ammonia.<sup>73</sup> Thus, the action
of a strong base on the COD ligand in compound **1**, in the
absence of more acidic reagents such as isopropanol that can
themselves be deprotonated, coordinate to the metal and then

<figure><img src="image_12.png" /><figcaption>Figure 7. Gibbs-energy profile (in kcal mol⁻¹) for the isomerisation of **4** to **5** by electronic rearrangement of the (1-κ-4,5,6-η³-C₈H₁₀) ligand.</figcaption></figure>
deliver a hydride ligand by β-H elimination (equation 4), induces a COD deprotonation with the stoichiometry depicted in equation 5 after chloride loss and β-H elimination. In this respect, it is also relevant to note the work of Kubiak *et al.*,⁸⁰ where the treatment of [Ir(COD)(triphos)]⁺Cl⁻ (triphos = bis(diphenylphosphinoethyl)phenylphosphine) with a variety of bases gave the [Ir(1-κ-5,6-η-C₈H₁₁)(triphos)] product. Here, the tridentate nature of triphos stops the β-H elimination process after deprotonation.

$$ \begin{array}{c} [\text{IrCl(COD)(dppe)}] + \text{tBuO}^{-} \rightarrow \\ \quad \begin{array}{c} \text{4 and 5} \\ \text{1} \end{array} \end{array} [\text{IrH(C}_8\text{H}_{10}\text{)(dppe)}] + \text{tBuOH} + \text{Cl}^{-} \quad (5) $$

### Compound 1 and KO'Bu in warm isopropanol. Formation of [IrH₄(dppe)]⁺

Upon heating the solution of the equilibrium mixture of **2** and **3**, either after isolation or *in situ* generation from **1**, in the presence of isopropanol and KO'Bu in C₇D₈ at 353 K, the ³¹P{¹H} resonances of both compounds decrease in intensity while that of the [IrH₄(dppe)]⁺ complex (**6**) increases. After 30 minutes the reaction is complete, with a single peak for **6** being observed (Figure S21). This complex is characterized by two distinct hydride resonances in a 1:1 ratio at δ -12.20 and δ -13.60 in the ¹H NMR spectrum (Figure 8) and a singlet at δ 44.2 in the ³¹P{¹H} NMR spectrum, coupled to both hydride resonances (Figure S22), while the ¹³C NMR spectrum (Figure S23) only shows the dppe ligand resonances. The equatorial hydrides (H₆) are equivalent, but differ in the way they are coupled to a specific P atom (*cis* or *trans*). Therefore, an AA'M₂XX' spin system is observed. The coupling pattern, established by selective decoupling experiments, is summarized in Figure 9 and Table S5. For H₆ we observe four independent coupling patterns (²J<sub>HH</sub>, ²J<sub>HHb</sub>, ²J<sub>HPcis</sub>, ²J<sub>HPtrans</sub>). The H₂H₆ coupling constant can be directly observed from the ¹H{³¹P} NMR spectrum. However, the full set of coupling constants had to be elucidated using NMR simulation tools (gNMR v5.0). The large splitting observed for H₆ in Figure 8 is a result of HP<sub>cis</sub> ± HP<sub>trans</sub>. The H₆ resonance, expected as a triplet of triplets, is observed as a septet, but selective decoupling from ³¹P yields only leaves the residual ²J<sub>HH</sub> coupling, observed as a binomial triplet.

<figure><img src="image_13.png" /><figcaption>Figure 8. Representative ¹H spectra in the hydride region for a solution of complex 6 in C₅D₈ at 298 K. (a) Regular ¹H spectrum. (b) ¹H{³¹P} spectrum. (c) H₆ resonance with selective decoupling from H₆.</figcaption></figure>

<figure><img src="image_14.png" /><figcaption>Figure 9. Schematic representation of the H-H and H-P coupling pattern in [IrH₄(dppe)]⁺. Coupling constants of H₆ and H₈ are shown in red and blue, respectively.</figcaption></figure>

Complex **6** could also be generated by warming the equilibrated solution of **4** and **5** in the presence of KO'Bu and isopropanol. In both cases, the liberation of free cyclooctene, *via* partial hydrogenation of COD or COT, was revealed by ¹H NMR. It should be noted that the addition of H₂ to solutions of **2/3** or **4/5** in C₆D₆ (or THF-d₈), without isopropanol, also produces **6** within 18 hours at room temperature, but only in the presence of KO'Bu because H₂ addition to a neutral hydride species cannot lead to an anionic product unless a proton is removed by a base. To further investigate the role of the base in forming **6**, H₂ (3 bar) was added to a solution of **1** in THF-d₈. Without base, both the ¹H (hydride region) and ³¹P{¹H} NMR spectra revealed a very complex pattern indicating the formation of several products, among which **2** and **3** could be identified, but not **6**. Equally complex mixtures resulted from the treatment of a THF-d₈ solution of pre-formed **2/3** (Figure S24) and **4/5** (Figure S25) with H₂ (3 bar) in the absence of base. The complete removal of the COD ligand with partial hydrogenation was indicated by the ¹H spectrum. The subsequent addition of K'OBu to these complex mixtures led to the selective production of **6**. When, on the other hand, K'OBu (5 equiv) was added first, both the **2/3** and **4/5** mixtures were selectively transformed to **6** (Figures S26 and S27, respectively). These collective results establish the thermodynamic feasibility of the formation of the anionic tetrahydride complex [IrH₄(dppe)]⁺ from **1** under both hydrogenation and transfer hydrogenation (from isopropanol) conditions in the presence of a strong base, according to the stepwise process and stoichiometry shown in Scheme 4.

<figure><img src="image_15.png" /></figure>
deliver a hydride ligand by β-H elimination (equation 4), induces a COD deprotonation with the stoichiometry depicted in equation 5 after chloride loss and β-H elimination. In this respect, it is also relevant to note the work of Kubiak *et al.*,⁸⁰ where the treatment of [Ir(COD)(triphos)]⁺Cl⁻ (triphos = bis(diphenylphosphinoethyl)phenylphosphine) with a variety of bases gave the [Ir(1-κ-5,6-η-C₈H₁₁)(triphos)] product. Here, the tridentate nature of triphos stops the β-H elimination process after deprotonation.

$$ \begin{array}{c} [\text{IrCl(COD)(dppe)}] + \text{tBuO}^{-} \rightarrow \\ \text{1} \qquad \text{4 and 5} \end{array} [\text{IrH(C}_8\text{H}_{10}\text{)(dppe)}] + \text{tBuOH} + \text{Cl}^{-} \quad (5) $$

### Compound 1 and KO'Bu in warm isopropanol. Formation of [IrH₄(dppe)]⁺

Upon heating the solution of the equilibrium mixture of **2** and **3**, either after isolation or *in situ* generation from **1**, in the presence of isopropanol and KO'Bu in C₇D₈ at 353 K, the ³¹P{¹H} resonances of both compounds decrease in intensity while that of the [IrH₄(dppe)]⁺ complex (**6**) increases. After 30 minutes the reaction is complete, with a single peak for **6** being observed (Figure S21). This complex is characterized by two distinct hydride resonances in a 1:1 ratio at δ -12.20 and δ -13.60 in the ¹H NMR spectrum (Figure 8) and a singlet at δ 44.2 in the ³¹P{¹H} NMR spectrum, coupled to both hydride resonances (Figure S22), while the ¹³C NMR spectrum (Figure S23) only shows the dppe ligand resonances. The equatorial hydrides (H₆) are equivalent, but differ in the way they are coupled to a specific P atom (*cis* or *trans*). Therefore, an AA'M₂XX' spin system is observed. The coupling pattern, established by selective decoupling experiments, is summarized in Figure 9 and Table S5. For H₆ we observe four independent coupling patterns (²J<sub>HH</sub>, ²J<sub>HHb</sub>, ²J<sub>HPcis</sub>, ²J<sub>HPtrans</sub>). The H₂H₆ coupling constant can be directly observed from the ¹H{³¹P} NMR spectrum. However, the full set of coupling constants had to be elucidated using NMR simulation tools (gNMR v5.0). The large splitting observed for H₆ in Figure 8 is a result of HP<sub>cis</sub> ± HP<sub>trans</sub>. The H₆ resonance, expected as a triplet of triplets, is observed as a septet, but selective decoupling from ³¹P yields only leaves the residual ²J<sub>HH</sub> coupling, observed as a binomial triplet.

<figure><img src="image_13.png" /><figcaption>Figure 8. Representative ¹H spectra in the hydride region for a solution of complex 6 in C₇D₈ at 298 K. (a) Regular ¹H spectrum. (b) ¹H{³¹P} spectrum. (c) H₆ resonance with selective decoupling from H₆.</figcaption></figure>

<figure><img src="image_14.png" /><figcaption>Figure 9. Schematic representation of the H-H and H-P coupling pattern in [IrH₄(dppe)]⁺. Coupling constants of H₆ and H₇ are shown in red and blue, respectively.</figcaption></figure>

Complex **6** could also be generated by warming the equilibrated solution of **4** and **5** in the presence of KO'Bu and isopropanol. In both cases, the liberation of free cyclooctene, *via* partial hydrogenation of COD or COT, was revealed by ¹H NMR. It should be noted that the addition of H₂ to solutions of **2/3** or **4/5** in C₆D₆ (or THF-d₈), without isopropanol, also produces **6** within 18 hours at room temperature, but only in the presence of KO'Bu because H₂ addition to a neutral hydride species cannot lead to an anionic product unless a proton is removed by a base. To further investigate the role of the base in forming **6**, H₂ (3 bar) was added to a solution of **1** in THF-d₈. Without base, both the ¹H (hydride region) and ³¹P{¹H} NMR spectra revealed a very complex pattern indicating the formation of several products, among which **2** and **3** could be identified, but not **6**. Equally complex mixtures resulted from the treatment of a THF-d₈ solution of pre-formed **2/3** (Figure S24) and **4/5** (Figure S25) with H₂ (3 bar) in the absence of base. The complete removal of the COD ligand with partial hydrogenation was indicated by the ¹H spectrum. The subsequent addition of K'OBu to these complex mixtures led to the selective production of **6**. When, on the other hand, K'OBu (5 equiv) was added first, both the **2/3** and **4/5** mixtures were selectively transformed to **6** (Figures S26 and S27, respectively). These collective results establish the thermodynamic feasibility of the formation of the anionic tetrahydride complex [IrH₄(dppe)]⁺ from **1** under both hydrogenation and transfer hydrogenation (from isopropanol) conditions in the presence of a strong base, according to the stepwise process and stoichiometry shown in Scheme 4.

<figure><img src="image_15.png" /></figure>
## Conclusions

We have experimentally demonstrated a route towards the formation of an iridium tetrahydrido complex 6 ([IrH₄(dppe)]⁺) from 1 [Ir(COD)(dppe)Cl], with elimination of cyclooctene under both hydrogenation and transfer hydrogenation (from isopropanol) conditions. This complex is formed in the presence of a strong base, with the cation of the base providing a suitable counterion to the tetrahydride 6. The use of a diphosphine ligand allowed the reaction mechanism to be explored in full due to the strong chelating effect. This has so far not been explored with the P,S-ligand system because of the higher reactivity and thus higher sensitivity. This is consistent with the computational study on ketone hydrogenation with 'non-N-H' ligands,⁴⁴ suggesting that an anionic tetrahydride species is the active catalyst.

Under ambient conditions in the absence of an alcohol in the solvent, the type of alkoxide has a marked effect on 1. When a β-hydrogen is present, the COD ligand maintains its chemical composition and two isomers of [IrH(C₈H₁₂)(dppe)], 2 and 3, are produced. When a base with no β-hydrogen is used, on the other hand, deprotonation of the COD fragment occurs with subsequent β-H elimination from the C₈H₁₁ fragment to yield two isomers of [IrH(C₈H₁₀)(dppe)], 4 and 5. We have fully characterized each product using NMR spectroscopy, while DFT calculations, in combination with the experimental kinetics of the generation and isomerization of the various products, explain the detailed mechanism of formation of each neutral hydride species and their interconversions.

The results of this work provide an insight into the catalytic action of [IrCl(LL)(COD)] complexes in the hydrogenation of polar substrates in the presence of a base.

## Author Contributions

PK; investigation, writing - original draft. EM; supervision; writing - review and editing. AL; formal analysis; writing - review and editing. ACW; investigation (X-ray diffraction). JL; supervision; writing - review and editing. JS; supervision; writing - review and editing. SBD; formal analysis; supervision; writing - review and editing. RP; conceptualization; funding acquisition; writing - review and editing.

## Conflicts of interest

There are no conflicts to declare.

## Acknowledgements

This work has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 860322, and was granted access to the resources of the CICT (Centre

Interuniversitaire de Calcul de Toulouse, project CALMIP). We are also grateful to the CNRS (Centre National de la Recherche Scientifique) for additional funding and to S.M. Wahidur Rahaman for a few initial investigations. JML is funded through a Royal Society Industrial Research fellowship.

## Notes and references

1. W. Tang and X. Zhang, *Chemical Reviews* (Washington, DC, United States), 2003, **103**, 3029-3069.

2. J. H. Xie, S. F. Zhu and Q. L. Zhou, *Chem. Rev.*, 2011, **111**, 1713-1760.

3. H.-U. Blaser, B. Pugin and F. Spindler, in *Organometallics as Catalysts in the Fine Chemical Industry*, eds. M. Beller and H. U. Blaser, 2012, vol. 42, pp. 65-102.

4. C. S. G. Seo and R. H. Morris, *Organometallics*, 2019, **38**, 47-65.

5. D.-S. Wang, Q.-A. Chen, S.-M. Lu and Y.-G. Zhou, *Chem. Rev.* (Washington, DC, U. S.), 2012, **112**, 2557-2590.

6. J. L. Wen, F. Y. Wang and X. M. Zhang, *Chem. Soc. Rev.*, 2021, **50**, 3211-3237.

7. G. Brieger and T. J. Nestrick, *Chem. Rev.*, 1974, **74**, 567-580.

8. G. Zassinovich, G. Mestroni and S. Gladiali, *Chemical Reviews* (Washington, DC, United States), 1992, **92**, 1051-1069.

9. M. J. Palmer and M. Wills, *Tetrahedron: Asymmetry*, 1999, **10**, 2045-2061.

10. S. Gladiali and E. Alberico, *Chem. Soc. Rev.*, 2006, **35**, 226-236.

11. C. Wang, X. F. Wu and J. L. Xiao, *Chem. Asian J.*, 2008, **3**, 1750-1770.

12. B. Stefane and F. Pozgan, *Catalysis Reviews-Science and Engineering*, 2014, **56**, 82-174.

13. D. Wang and D. Astruc, *Chem. Rev.*, 2015, **115**, 6621-6686.

14. B. Stefane and F. Pozgan, *Topics in Current Chemistry*, 2016, **374**.

15. S. J. Roseblade and A. Pfaltz, *C. R. Chim.*, 2007, **10**, 178-187.

16. X. F. Wu, X. H. Li, A. Zanotti-Gerosa, A. Pettman, J. K. Liu, A. J. Mills and J. L. Xiao, *Chem. Eur. J.*, 2008, **14**, 2209-2222.

17. J. K. Liu, X. F. Wu, J. A. Iggo and J. L. Xiao, *Coord. Chem. Rev.*, 2008, **252**, 782-809.

18. C. Bianchini, L. Gonsalvi and M. Peruzzini, in *Iridium Complexes in Organic Synthesis*, eds. L. A. Oro and C. Claver, Wiley-VCH, Weinheim, 2009, pp. 55-106.

19. R. Malacea, R. Poli and E. Manoury, *Coord. Chem. Rev.*, 2010, **254**, 729-752.

20. D. H. Woodmansee and A. Pfalz, in *Iridium Catalysis*, ed. P. G. Andersson, Springer, Berlin, 2011, vol. 34, pp. 31-76.

21. A. Cadu and P. G. Andersson, *J. Organomet. Chem.*, 2012, **714**, 3-11.

22. K. H. Hopmann and A. Bayer, *Coord. Chem. Rev.*, 2014, **268**, 59-82.

23. C. X. Cui, H. H. Chen, S. J. Li, T. Zhang, L. B. Qu and Y. Lan, *Coord. Chem. Rev.*, 2020, **412**.

24. A. Fabrello, A. Bachelier, M. Urrutigoity and P. Kalck, *Coord. Chem. Rev.*, 2010, **254**, 273-287.

25. A. Comas-Vives, G. Ujaque and A. Lledós, *Adv. Inorg. Chem.*, 2010, **62**, 231-260.

26. R. Poli, *Adv. Organometal. Chem.*, in press.

27. P. Kvintovics, J. Bakos and B. Heil, *J. Mol. Catal.*, 1985, **32**, 111-114.

Dalton Transactions Accepted Manuscript

<figure><img src="image_16.png" /></figure>
Scheme 4. Idealized stoichiometry (further cyclooctene hydrogenation may also occur) for the [IrH₄(dppe)]⁺ generation from [IrCl(dppe)(COD)] under both hydrogenation and transfer hydrogenation conditions in isopropanol.

## Conclusions

We have experimentally demonstrated a route towards the formation of an iridium tetrahydrido complex 6 ([IrH₄(dppe)]⁺) from 1 [Ir(COD)(dppe)Cl], with elimination of cyclooctene under both hydrogenation and transfer hydrogenation (from isopropanol) conditions. This complex is formed in the presence of a strong base, with the cation of the base providing a suitable counterion to the tetrahydride 6. The use of a diphosphine ligand allowed the reaction mechanism to be explored in full due to the strong chelating effect. This has so far not been explored with the P,S-ligand system because of the higher reactivity and thus higher sensitivity. This is consistent with the computational study on ketone hydrogenation with 'non-N-H' ligands,⁴⁴ suggesting that an anionic tetrahydride species is the active catalyst.

Under ambient conditions in the absence of an alcohol in the solvent, the type of alkoxide has a marked effect on 1. When a β-hydrogen is present, the COD ligand maintains its chemical composition and two isomers of [IrH(C₈H₁₂)(dppe)], 2 and 3, are produced. When a base with no β-hydrogen is used, on the other hand, deprotonation of the COD fragment occurs with subsequent β-H elimination from the C₈H₁₁ fragment to yield two isomers of [IrH(C₈H₁₀)(dppe)], 4 and 5. We have fully characterized each product using NMR spectroscopy, while DFT calculations, in combination with the experimental kinetics of the generation and isomerization of the various products, explain the detailed mechanism of formation of each neutral hydride species and their interconversions.

The results of this work provide an insight into the catalytic action of [IrCl(LL)(COD)] complexes in the hydrogenation of polar substrates in the presence of a base.

## Author Contributions

PK; investigation, writing - original draft. EM; supervision; writing - review and editing. AL; formal analysis; writing - review and editing. ACW; investigation (X-ray diffraction). JL; supervision; writing - review and editing. JS; supervision; writing - review and editing. SBD; formal analysis; supervision; writing - review and editing. RP; conceptualization; funding acquisition; writing - review and editing.

## Conflicts of interest

There are no conflicts to declare.

## Acknowledgements

This work has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 860322, and was granted access to the resources of the CICT (Centre

Interuniversitaire de Calcul de Toulouse, project CALMIP). We are also grateful to the CNRS (Centre National de la Recherche Scientifique) for additional funding and to S.M. Wahidur Rahaman for a few initial investigations. JML is funded through a Royal Society Industrial Research fellowship.

## Notes and references

1. W. Tang and X. Zhang, *Chemical Reviews* (Washington, DC, United States), 2003, **103**, 3029-3069.

2. J. H. Xie, S. F. Zhu and Q. L. Zhou, *Chem. Rev.*, 2011, **111**, 1713-1760.

3. H.-U. Blaser, B. Pugin and F. Spindler, in *Organometallics as Catalysts in the Fine Chemical Industry*, eds. M. Beller and H. U. Blaser, 2012, vol. 42, pp. 65-102.

4. C. S. G. Seo and R. H. Morris, *Organometallics*, 2019, **38**, 47-65.

5. D.-S. Wang, Q.-A. Chen, S.-M. Lu and Y.-G. Zhou, *Chem. Rev.* (Washington, DC, U. S.), 2012, **112**, 2557-2590.

6. J. L. Wen, F. Y. Wang and X. M. Zhang, *Chem. Soc. Rev.*, 2021, **50**, 3211-3237.

7. G. Brieger and T. J. Nestrick, *Chem. Rev.*, 1974, **74**, 567-580.

8. G. Zassinovich, G. Mestroni and S. Gladiali, *Chemical Reviews* (Washington, DC, United States), 1992, **92**, 1051-1069.

9. M. J. Palmer and M. Wills, *Tetrahedron: Asymmetry*, 1999, **10**, 2045-2061.

10. S. Gladiali and E. Alberico, *Chem. Soc. Rev.*, 2006, **35**, 226-236.

11. C. Wang, X. F. Wu and J. L. Xiao, *Chem. Asian J.*, 2008, **3**, 1750-1770.

12. B. Stefane and F. Pozgan, *Catalysis Reviews-Science and Engineering*, 2014, **56**, 82-174.

13. D. Wang and D. Astruc, *Chem. Rev.*, 2015, **115**, 6621-6686.

14. B. Stefane and F. Pozgan, *Topics in Current Chemistry*, 2016, **374**.

15. S. J. Roseblade and A. Pfaltz, *C. R. Chim.*, 2007, **10**, 178-187.

16. X. F. Wu, X. H. Li, A. Zanotti-Gerosa, A. Pettman, J. K. Liu, A. J. Mills and J. L. Xiao, *Chem. Eur. J.*, 2008, **14**, 2209-2222.

17. J. K. Liu, X. F. Wu, J. A. Iggo and J. L. Xiao, *Coord. Chem. Rev.*, 2008, **252**, 782-809.

18. C. Bianchini, L. Gonsalvi and M. Peruzzi, in *Iridium Complexes in Organic Synthesis*, eds. L. A. Oro and C. Claver, Wiley-VCH, Weinheim, 2009, pp. 55-106.

19. R. Malacea, R. Poli and E. Manoury, *Coord. Chem. Rev.*, 2010, **254**, 729-752.

20. D. H. Woodmansee and A. Pfalz, in *Iridium Catalysis*, ed. P. G. Andersson, Springer, Berlin, 2011, vol. 34, pp. 31-76.

21. A. Cadu and P. G. Andersson, *J. Organomet. Chem.*, 2012, **714**, 3-11.

22. K. H. Hopmann and A. Bayer, *Coord. Chem. Rev.*, 2014, **268**, 59-82.

23. C. X. Cui, H. H. Chen, S. J. Li, T. Zhang, L. B. Qu and Y. Lan, *Coord. Chem. Rev.*, 2020, **412**.

24. A. Fabrello, A. Bachelier, M. Urrutigoity and P. Kalck, *Coord. Chem. Rev.*, 2010, **254**, 273-287.

25. A. Comas-Vives, G. Ujaque and A. Lledós, *Adv. Inorg. Chem.*, 2010, **62**, 231-260.

26. R. Poli, *Adv. Organometal. Chem.*, in press.

27. P. Kvintovics, J. Bakos and B. Heil, *J. Mol. Catal.*, 1985, **32**, 111-114.

Dalton Transactions Accepted Manuscript

<figure><img src="image_16.png" /></figure>
ARTICLE

28. R. Spogliarich, J. Kaspar, M. Graziani and F. Morandini, *J. Organomet. Chem.*, 1986, **306**, 407-412.

29. G. Zassinovich and G. Mestroni, *J. Mol. Catal.*, 1987, **42**, 81-90.

30. M. Bernard, V. Guiral, F. Delbecq, F. Fache, P. Sautet and M. Lemaire, *J. Am. Chem. Soc.*, 1998, **120**, 1441-1446.

31. D. G. I. Petra, P. C. J. Kamer, A. L. Spek, H. E. Schoemaker and P. W. N. M. Van Leeuwen, *J. Org. Chem.*, 2000, **65**, 3010-3017.

32. V. Guiral, F. Delbecq and P. Sautet, *Organometallics*, 2000, **19**, 1589-1598.

33. V. Guiral, F. Delbecq and P. Sautet, *Organometallics*, 2001, **20**, 2207-2214.

34. F. Delbecq, V. Guiral and P. Sautet, *Eur. J. Org. Chem.*, 2003, 2092-2097.

35. J. W. Handgraaf, J. N. H. Reek and E. J. Meijer, *Organometallics*, 2003, **22**, 3150-3157.

36. M. V. Jimenez, J. Fernandez-Tornos, J. J. Perez-Torrente, F. J. Modrego, S. Winterle, C. Cunchillos, F. J. Lahoz and L. A. Oro, *Organometallics*, 2011, **30**, 5493-5508.

37. S. A. Popoola, E. A. Jaseer, A. A. Al-Saadi, V. Polo, M. A. Casado and L. A. Oro, *Inorg. Chim. Acta*, 2015, **436**, 146-151.

38. M. V. Jimenez, J. Fernandez-Tornos, J. J. Perez-Torrente, F. J. Modrego, P. Garcia-Orduna and L. A. Oro, *Organometallics*, 2015, **34**, 926-940.

39. N. Garcia, E. A. Jaseer, J. Munarriz, P. J. Sanz Miguel, V. Polo, M. Iglesias and L. A. Oro, *Eur. J. Inorg. Chem.*, 2015, DOI: 10.1002/ejic.201500853, 4388-4395.

40. A. Iturmendi, N. Garcia, E. A. Jaseer, J. Munarriz, P. J. S. Miguel, V. Polo, M. Iglesias and L. A. Oro, *Dalton Trans.*, 2016, **45**, 12835-12845.

41. R. Malacea, J.-C. Daran, S. B. Duckett, J. P. Dunne, C. Godard, E. Manoury, R. Poli and A. C. Whitwood, *Dalton Trans.*, 2006, 3350-3359.

42. R. Malacea, E. Manoury, L. Routaboul, J.-C. Daran, R. Poli, J. P. Dunne, A. C. Withwood, C. Godard and S. B. Duckett, *Eur. J. Inorg. Chem.*, 2006, 1803-1816.

43. E. Le Roux, R. Malacea, E. Manoury, R. Poli, L. Gonsalvi and M. Peruzzini, *Adv. Synth. Catal.*, 2007, **349**, 309-313.

44. J. M. Hayes, E. Deydier, G. Ujaque, A. Lledós, R. Malacea-Kabbara, E. Manoury, S. Vincendeau and R. Poli, *ACS Catal.*, 2015, **5**, 4368-4376.

45. C. A. Sandoval, T. Ohkuma, K. Muniz and R. Noyori, *J. Am. Chem. Soc.*, 2003, **125**, 13490-13503.

46. K. Abdur-Rashid, D. G. Gusev, S. E. Landau, A. J. Lough and R. H. Morris, *J. Am. Chem. Soc.*, 1998, **120**, 11826-11827.

47. S. E. Landau, K. E. Groh, A. J. Lough and R. H. Morris, *Inorg. Chem.*, 2002, **41**, 2995-3007.

48. S. M. W. Rahaman, J.-C. Daran, E. Manoury and R. Poli, *J. Organomet. Chem*, 2017, **829**, 14-21.

49. T. Makino, Y. Yamamoto and K. Itoh, *Organometallics*, 2004, **23**, 1730-1737.

50. M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. A. Petersson, H. Nakatsuji, M. Caricato, X. Li, H. P. Hratchian, A. F. Izmaylov, J. Bloino, G. Zheng, J. L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J. A. Montgomery Jr., J. E. Peralta, F. Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers, K. N. Kudin, V. N. Staroverov, R. Kobayashi, J. Normand, K. Raghavachari, A. Rendell, J. C. Burant, S. S. Iyengar, J. Tomasi, M. Cossi, N. Rega, N. J. Millam, M. Klene, J. E. Knox, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, R. L. Martin, K. Morokuma, V. G. Zakrzewski, G. A. Voth, P. Salvador, J. J. Dannenberg, S. Dapprich, A. D. Daniels, Ö. Farkas, J. B. Foresman, J. V. Ortiz, J. Cioslowski and D. J. Fox, *Gaussian 09, Revision D.01*, Gaussian, Inc., Wallingford CT, 2009.

C. T. Lee, W. T. Yang and R. G. Parr, *Phys. Rev. B*, 1988, **37**, 785-789.

B. Miehlich, A. Savin, H. Stoll and H. Preuss, *Chem. Phys. Lett.*, 1989, **157**, 200-206.

A. D. Becke, *J. Chem. Phys.*, 1993, **98**, 5648-5652.

S. Grimme, J. Antony, S. Ehrlich and H. Krieg, *J. Chem. Phys.*, 2010, **132**, 154104.

A. V. Marenich, C. J. Cramer and D. G. Truhlar, *J. Phys. Chem. B*, 2009, **113**, 6378-6396.

W. J. Hehre, R. Ditchfield and J. A. Pople, *J. Chem. Phys.*, 1972, **56**, 2257-2261.

M. M. Francl, W. J. Pietro, W. J. Hehre, J. S. Binkley, M. S. Gordon, D. J. Defrees and J. A. Pople, *J. Chem. Phys.*, 1982, **77**, 3654-3665.

D. Andrae, U. Haussermann, M. Dolg, H. Stoll and H. Preuss, *Theor. Chim. Acta*, 1990, **77**, 123-141.

A. W. Ehlers, M. Böhme, S. Dapprich, A. Gobbi, A. Hoellwarth, V. Jonas, K. F. Koehler, R. Stegmann, A. Veldkamp and G. Frenking, *Chem. Phys. Lett.*, 1993, **208**, 111-114.

F. Weigend and R. Ahlrichs, *Phys. Chem. Chem. Phys.*, 2005, **7**, 3297-3305.

V. S. Bryantsev, M. S. Diallo and W. A. Goddard, III, *J. Phys. Chem. B*, 2008, **112**, 9709-9719.

M. Bikrani, L. Fidalgo and M. A. Garralda, *Polyhedron*, 1996, **15**, 83-89.

L. D. Field, B. A. Messerle, M. Rehr, L. P. Soler and T. W. Hambley, *Organometallics*, 2003, **22**, 2387-2395.

M. A. Esteruelas, L. A. Oro, M. C. Apreda, C. Foces-Foces, F. H. Cano, R. M. Claramunt, C. Lopez, J. Elguero and M. Begtrup, *J. Organomet. Chem.*, 1988, **344**, 93-108.

C. Laborde, M.-M. Wei, A. van der Lee, E. Deydier, J.-C. Daran, J.-N. Volle, R. Poli, J.-L. Pirat, E. Manoury and D. Virieux, *Dalton Trans.*, 2015, **44**, 12539-12545.

R. C. Schnabel and D. M. Roddick, *Inorg. Chem.*, 1993, **32**, 1513-1518.

O. Tissot, M. Mouygou, F. Dallemer, J. Daran and G. Balavoine, *Eur. J. Inorg. Chem.*, 2001, 2385-2389.

M. J. Fernandez, M. A. Esteruelas, M. Covarrubias and L. A. Oro, *J. Organomet. Chem.*, 1986, **316**, 343-349.

M. Fabbian, N. Marsich and E. Farnetti, *Inorg. Chim. Acta*, 2004, **357**, 2881-2888.

P. Meakin, J. P. Jesson and E. L. Muetterties, *J. Am. Chem. Soc.*, 1972, **94**, 5271-5285.

B. K. Teo, A. P. Ginsberg and J. C. Calabrese, *J. Am. Chem. Soc.*, 1976, **98**, 3027-3028.

M. A. Esteruelas, M. Oliván, L. A. Oro, M. Schulz, E. Sola and H. Werner, *Organometallics*, 1992, **11**, 3659-3664.

I. Mena, P. Garcia-Orduna, V. Polo, F. J. Lahoz, M. A. Casado and L. A. Oro, *Dalton Trans.*, 2017, **46**, 11459-11468.

J. Evans, B. F. G. Johnson and J. Lewis, *J. Chem. Soc., Dalton Trans.*, 1972, 2668.

<figure><img src="image_17.png" /></figure>
ARTICLE

28. R. Spogliarich, J. Kaspar, M. Graziani and F. Morandini, *J. Organomet. Chem.*, 1986, **306**, 407-412.

29. G. Zassinovich and G. Mestroni, *J. Mol. Catal.*, 1987, **42**, 81-90.

30. M. Bernard, V. Guiral, F. Delbecq, F. Fache, P. Sautet and M. Lemaire, *J. Am. Chem. Soc.*, 1998, **120**, 1441-1446.

31. D. G. I. Petra, P. C. J. Kamer, A. L. Spek, H. E. Schoemaker and P. W. N. M. Van Leeuwen, *J. Org. Chem.*, 2000, **65**, 3010-3017.

32. V. Guiral, F. Delbecq and P. Sautet, *Organometallics*, 2000, **19**, 1589-1598.

33. V. Guiral, F. Delbecq and P. Sautet, *Organometallics*, 2001, **20**, 2207-2214.

34. F. Delbecq, V. Guiral and P. Sautet, *Eur. J. Org. Chem.*, 2003, 2092-2097.

35. J. W. Handgraaf, J. N. H. Reek and E. J. Meijer, *Organometallics*, 2003, **22**, 3150-3157.

36. M. V. Jimenez, J. Fernandez-Tornos, J. J. Perez-Torrente, F. J. Modrego, S. Winterle, C. Cunchillos, F. J. Lahoz and L. A. Oro, *Organometallics*, 2011, **30**, 5493-5508.

37. S. A. Popoola, E. A. Jaseer, A. A. Al-Saadi, V. Polo, M. A. Casado and L. A. Oro, *Inorg. Chim. Acta*, 2015, **436**, 146-151.

38. M. V. Jimenez, J. Fernandez-Tornos, J. J. Perez-Torrente, F. J. Modrego, P. Garcia-Orduna and L. A. Oro, *Organometallics*, 2015, **34**, 926-940.

39. N. Garcia, E. A. Jaseer, J. Munarriz, P. J. Sanz Miguel, V. Polo, M. Iglesias and L. A. Oro, *Eur. J. Inorg. Chem.*, 2015, DOI: 10.1002/ejic.201500853, 4388-4395.

40. A. Iturmendi, N. Garcia, E. A. Jaseer, J. Munarriz, P. J. S. Miguel, V. Polo, M. Iglesias and L. A. Oro, *Dalton Trans.*, 2016, **45**, 12835-12845.

41. R. Malacea, J.-C. Daran, S. B. Duckett, J. P. Dunne, C. Godard, E. Manoury, R. Poli and A. C. Whitwood, *Dalton Trans.*, 2006, 3350-3359.

42. R. Malacea, E. Manoury, L. Routaboul, J.-C. Daran, R. Poli, J. P. Dunne, A. C. Withwood, C. Godard and S. B. Duckett, *Eur. J. Inorg. Chem.*, 2006, 1803-1816.

43. E. Le Roux, R. Malacea, E. Manoury, R. Poli, L. Gonsalvi and M. Peruzzini, *Adv. Synth. Catal.*, 2007, **349**, 309-313.

44. J. M. Hayes, E. Deydier, G. Ujaque, A. Lledós, R. Malacea-Kabbara, E. Manoury, S. Vincendeau and R. Poli, *ACS Catal.*, 2015, **5**, 4368-4376.

45. C. A. Sandoval, T. Ohkuma, K. Muniz and R. Noyori, *J. Am. Chem. Soc.*, 2003, **125**, 13490-13503.

46. K. Abdur-Rashid, D. G. Gusev, S. E. Landau, A. J. Lough and R. H. Morris, *J. Am. Chem. Soc.*, 1998, **120**, 11826-11827.

47. S. E. Landau, K. E. Groh, A. J. Lough and R. H. Morris, *Inorg. Chem.*, 2002, **41**, 2995-3007.

48. S. M. W. Rahaman, J.-C. Daran, E. Manoury and R. Poli, *J. Organomet. Chem*, 2017, **829**, 14-21.

49. T. Makino, Y. Yamamoto and K. Itoh, *Organometallics*, 2004, **23**, 1730-1737.

50. M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. A. Petersson, H. Nakatsuji, M. Caricato, X. Li, H. P. Hratchian, A. F. Izmaylov, J. Bloino, G. Zheng, J. L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J. A. Montgomery Jr., J. E. Peralta, F. Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers, K. N. Kudin, V. N. Staroverov, R. Kobayashi, J. Normand, K. Raghavachari, A. Rendell, J. C. Burant, S. S. Iyengar, J. Tomasi, M. Cossi, N. Rega, N. J. Millam, M. Klene, J. E. Knox, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, R. L. Martin, K. Morokuma, V. G. Zakrzewski, G. A. Voth, P. Salvador, J. J. Dannenberg, S. Dapprich, A. D. Daniels, Ö. Farkas, J. B. Foresman, J. V. Ortiz, J. Cioslowski and D. J. Fox, *Gaussian 09, Revision D.01*, Gaussian, Inc., Wallingford CT, 2009.

C. T. Lee, W. T. Yang and R. G. Parr, *Phys. Rev. B*, 1988, **37**, 785-789.

B. Miehlich, A. Savin, H. Stoll and H. Preuss, *Chem. Phys. Lett.*, 1989, **157**, 200-206.

A. D. Becke, *J. Chem. Phys.*, 1993, **98**, 5648-5652.

S. Grimme, J. Antony, S. Ehrlich and H. Krieg, *J. Chem. Phys.*, 2010, **132**, 154104.

A. V. Marenich, C. J. Cramer and D. G. Truhlar, *J. Phys. Chem. B*, 2009, **113**, 6378-6396.

W. J. Hehre, R. Ditchfield and J. A. Pople, *J. Chem. Phys.*, 1972, **56**, 2257-2261.

M. M. Francl, W. J. Pietro, W. J. Hehre, J. S. Binkley, M. S. Gordon, D. J. Defrees and J. A. Pople, *J. Chem. Phys.*, 1982, **77**, 3654-3665.

D. Andrae, U. Haussermann, M. Dolg, H. Stoll and H. Preuss, *Theor. Chim. Acta*, 1990, **77**, 123-141.

A. W. Ehlers, M. Böhme, S. Dapprich, A. Gobbi, A. Hoellwarth, V. Jonas, K. F. Koehler, R. Stegmann, A. Veldkamp and G. Frenking, *Chem. Phys. Lett.*, 1993, **208**, 111-114.

E. Weigend and R. Ahlrichs, *Phys. Chem. Chem. Phys.*, 2005, **7**, 3297-3305.

V. S. Bryantsev, M. S. Diallo and W. A. Goddard, III, *J. Phys. Chem. B*, 2008, **112**, 9709-9719.

M. Bikrani, L. Fidalgo and M. A. Garralda, *Polyhedron*, 1996, **15**, 83-89.

L. D. Field, B. A. Messerle, M. Rehr, L. P. Soler and T. W. Hambley, *Organometallics*, 2003, **22**, 2387-2395.

M. A. Esteruelas, L. A. Oro, M. C. Apreda, C. Foces-Foces, F. H. Cano, R. M. Claramunt, C. Lopez, J. Elguero and M. Begtrup, *J. Organomet. Chem.*, 1988, **344**, 93-108.

C. Laborde, M.-M. Wei, A. van der Lee, E. Deydier, J.-C. Daran, J.-N. Volle, R. Poli, J.-L. Pirat, E. Manoury and D. Virieux, *Dalton Trans.*, 2015, **44**, 12539-12545.

R. C. Schnabel and D. M. Roddick, *Inorg. Chem.*, 1993, **32**, 1513-1518.

O. Tissot, M. Mouygou, F. Dallemer, J. Daran and G. Balavoine, *Eur. J. Inorg. Chem.*, 2001, 2385-2389.

M. J. Fernandez, M. A. Esteruelas, M. Covarrubias and L. A. Oro, *J. Organomet. Chem.*, 1986, **316**, 343-349.

M. Fabbian, N. Marsich and E. Farnetti, *Inorg. Chim. Acta*, 2004, **357**, 2881-2888.

P. Meakin, J. P. Jesson and E. L. Muetterties, *J. Am. Chem. Soc.*, 1972, **94**, 5271-5285.

B. K. Teo, A. P. Ginsberg and J. C. Calabrese, *J. Am. Chem. Soc.*, 1976, **98**, 3027-3028.

M. A. Esteruelas, M. Oliván, L. A. Oro, M. Schulz, E. Sola and H. Werner, *Organometallics*, 1992, **11**, 3659-3664.

I. Mena, P. Garcia-Orduna, V. Polo, F. J. Lahoz, M. A. Casado and L. A. Oro, *Dalton Trans.*, 2017, **46**, 11459-11468.

J. Evans, B. F. G. Johnson and J. Lewis, *J. Chem. Soc., Dalton Trans.*, 1972, 2668.

<figure><img src="image_17.png" /></figure>
Journal Name

75. R. P. Aggarwal, N. G. Connelly, B. J. Dunne, M. Gilbert and A. G. Orpen, *J. Chem. Soc., Dalton Trans.*, 1991, DOI: 10.1039/dt9910000001, 1-9.

76. F. J. Liotta, G. Vanduyne and B. K. Carpenter, *Organometallics*, 1987, **6**, 1010-1023.

77. T. Suzuki, M. Shiotsuki, K. Wada, T. Kondo and T. A. Mitsudo, *J. Chem. Soc., Dalton Trans.*, 1999, DOI: 10.1039/a907333g, 4231-4237.

78. M. Shiotsuki, H. Miyai, Y. Ura, T. Suzuki, T. Kondo and T. Mitsudo, *Organometallics*, 2002, **21**, 4960-4964.

79. T. Suzuki, M. Shiotsuki, K. Wada, T. Kondo and T. Mitsudo, *Organometallics*, 1999, **18**, 3671-3678.

80. A. M. Gull, P. E. Fanwick and C. P. Kubiak, *Organometallics*, 1993, **12**, 2121-2125.
Journal Name

75. R. P. Aggarwal, N. G. Connelly, B. J. Dunne, M. Gilbert and A. G. Orpen, *J. Chem. Soc., Dalton Trans.*, 1991, DOI: 10.1039/dt9910000001, 1-9.

76. F. J. Liotta, G. Vanduyne and B. K. Carpenter, *Organometallics*, 1987, **6**, 1010-1023.

77. T. Suzuki, M. Shiotsuki, K. Wada, T. Kondo and T. A. Mitsudo, *J. Chem. Soc., Dalton Trans.*, 1999, DOI: 10.1039/a907333g, 4231-4237.

78. M. Shiotsuki, H. Miyai, Y. Ura, T. Suzuki, T. Kondo and T. Mitsudo, *Organometallics*, 2002, **21**, 4960-4964.

79. T. Suzuki, M. Shiotsuki, K. Wada, T. Kondo and T. Mitsudo, *Organometallics*, 1999, **18**, 3671-3678.

80. A. M. Gull, P. E. Fanwick and C. P. Kubiak, *Organometallics*, 1993, **12**, 2121-2125.

<figure><img src="image_18.png" /></figure>